A	O
novel	O
mitogen-inducible	B-protein
gene	I-protein
product	I-protein
related	O
to	O
p50/p105-NF-kappa	B-protein
B	I-protein
participates	O
in	O
transactivation	O
through	O
a	O
kappa	B-DNA
B	I-DNA
site	I-DNA
.	O

A	O
Rel-related	B-protein
,	I-protein
mitogen-inducible	I-protein
,	I-protein
kappa	I-protein
B-binding	I-protein
protein	I-protein
has	O
been	O
cloned	O
as	O
an	O
immediate-early	B-DNA
activation	I-DNA
gene	I-DNA
of	O
human	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

The	O
cDNA	B-DNA
has	O
an	O
open	B-DNA
reading	I-DNA
frame	I-DNA
of	O
900	B-DNA
amino	I-DNA
acids	I-DNA
capable	O
of	O
encoding	O
a	O
97-kDa	B-protein
protein	I-protein
.	O

This	O
protein	O
is	O
most	O
similar	O
to	O
the	O
105-kDa	O
precursor	O
polypeptide	O
of	O
p50-NF-kappa	B-protein
B	I-protein
.	O

Like	O
the	O
105-kDa	O
precursor	O
,	O
it	O
contains	O
an	O
amino-terminal	B-protein
Rel-related	I-protein
domain	I-protein
of	O
about	O
300	O
amino	O
acids	O
and	O
a	O
carboxy-terminal	B-protein
domain	I-protein
containing	O
six	O
full	B-protein
cell	I-protein
cycle	I-protein
or	O
ankyrin	B-protein
repeats	I-protein
.	O

In	O
vitro-translated	B-protein
proteins	I-protein
,	O
truncated	O
downstream	O
of	O
the	O
Rel	B-DNA
domain	I-DNA
and	O
excluding	O
the	O
repeats	O
,	O
bind	O
kappa	B-DNA
B	I-DNA
sites	I-DNA
.	O

We	O
refer	O
to	O
the	O
kappa	B-protein
B-binding	I-protein
,	I-protein
truncated	I-protein
protein	I-protein
as	O
p50B	B-protein
by	O
analogy	O
with	O
p50-NF-kappa	B-protein
B	I-protein
and	O
to	O
the	O
full-length	O
protein	O
as	O
p97	B-protein
.	O

p50B	B-protein
is	O
able	O
to	O
form	O
heteromeric	B-protein
kappa	I-protein
B-binding	I-protein
complexes	I-protein
with	O
RelB	B-protein
,	O
as	O
well	O
as	O
with	O
p65	B-protein
and	O
p50	B-protein
,	O
the	O
two	O
subunits	O
of	O
NF-kappa	B-protein
B	I-protein
.	O

Transient-transfection	O
experiments	O
in	O
embryonal	B-cell_line
carcinoma	I-cell_line
cells	I-cell_line
demonstrate	O
a	O
functional	O
cooperation	O
between	O
p50B	B-protein
and	O
RelB	B-protein
or	O
p65	B-protein
in	O
transactivation	O
of	O
a	O
reporter	B-DNA
plasmid	I-DNA
dependent	O
on	O
a	O
kappa	B-DNA
B	I-DNA
site	I-DNA
.	O

The	O
data	O
imply	O
the	O
existence	O
of	O
a	O
complex	O
family	O
of	O
NF-kappa	B-protein
B-like	I-protein
transcription	I-protein
factors	I-protein
.	O

MoLECULAR	NULL
aND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
Feb.	NULL
1992	NULL
,	NULL
p.	NULL
685-695	NULL
0270-7306/92/020685-11	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1992	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

12	NULL
,	NULL
No	NULL
.	NULL

2	NULL
A	NULL
Novel	NULL
Mitogen-Inducible	NULL
Gene	NULL
Product	NULL
Related	NULL
to	NULL
p50/p105-NF-kB	NULL
Participates	NULL
in	NULL
Transactivation	NULL
through	NULL
a	NULL
kB	NULL
Site	NULL
VINCENT	NULL
BOURS	NULL
,	NULL
'	NULL
PARRIS	NULL
R.	NULL
BURD	NULL
,	NULL
'+	NULL
KEITH	NULL
BROWN	NULL
,	NULL
'¢	NULL
JUANITA	NULL
VILLALOBOS	NULL
,	NULL
'	NULL
SUN	NULL
PARK	NULL
,	NULL
``	NULL
ROLF-PETER	NULL
RYSECK	NULL
,	NULL
``	NULL
RODRIGO	NULL
BRAVO	NULL
,	NULL
``	NULL
KATHY	NULL
KELLY	NULL
,	NULL
anp	NULL
ULRICH	NULL
SIEBENLIST'*	NULL
Laboratory	NULL
of	NULL
Immunoregulation	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
,	NULL
``	NULL
and	NULL
Laboratory	NULL
of	NULL
Pathology	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
``	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892	NULL
,	NULL
and	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Bristol	NULL
Myers	NULL
Squibb	NULL
Pharmaceutical	NULL
Research	NULL
Institute	NULL
,	NULL
Princeton	NULL
,	NULL
New	NULL
Jersey	NULL
,	NULL
08543	NULL
``	NULL
Received	NULL
23	NULL
September	NULL
1991/Accepted	NULL
15	NULL
November	NULL
1991	NULL
A	NULL
Rel-related	NULL
,	NULL
mitogen-inducible	NULL
,	NULL
«	NULL
B-binding	NULL
protein	NULL
has	NULL
been	NULL
cloned	NULL
as	NULL
an	NULL
immediate-early	NULL
activation	NULL
gene	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
,	NULL
The	NULL
cDNA	NULL
has	NULL
an	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
900	NULL
amino	NULL
acids	NULL
capable	NULL
of	NULL
encoding	NULL
a	NULL
97-kDa	NULL
protein	NULL
.	NULL

This	NULL
protein	NULL
is	NULL
most	NULL
similar	NULL
to	NULL
the	NULL
105-kDa	NULL
precursor	NULL
polypeptide	NULL
of	NULL
pS0-NF-KB	NULL
.	NULL

Like	NULL
the	NULL
105-kDa	NULL
precursor	NULL
,	NULL
it	NULL
contains	NULL
an	NULL
amino-terminal	NULL
Rel-related	NULL
domain	NULL
of	NULL
about	NULL
300	NULL
amino	NULL
acids	NULL
and	NULL
a	NULL
carboxy-terminal	NULL
domain	NULL
containing	NULL
six	NULL
full	NULL
cell	NULL
cycle	NULL
or	NULL
ankyrin	NULL
repeats	NULL
.	NULL

In	NULL
vitro-translated	NULL
proteins	NULL
,	NULL
truncated	NULL
downstream	NULL
of	NULL
the	NULL
Rel	NULL
domain	NULL
and	NULL
excluding	NULL
the	NULL
repeats	NULL
,	NULL
bind	NULL
B	NULL
sites	NULL
.	NULL

We	NULL
refer	NULL
to	NULL
the	NULL
«	NULL
B-binding	NULL
,	NULL
truncated	NULL
protein	NULL
as	NULL
p50B	NULL
by	NULL
analogy	NULL
with	NULL
p50-NF-	NULL
«	NULL
B	NULL
and	NULL
to	NULL
the	NULL
full-length	NULL
protein	NULL
as	NULL
p97	NULL
.	NULL

p50B	NULL
is	NULL
able	NULL
to	NULL
form	NULL
heteromeric	NULL
«	NULL
B-binding	NULL
complexes	NULL
with	NULL
RelB	NULL
,	NULL
as	NULL
well	NULL
as	NULL
with	NULL
p65	NULL
and	NULL
p50	NULL
,	NULL
the	NULL
two	NULL
subunits	NULL
of	NULL
NF-KB	NULL
.	NULL

Transient-transfection	NULL
experiments	NULL
in	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
demonstrate	NULL
a	NULL
functional	NULL
cooperation	NULL
between	NULL
p50B	NULL
and	NULL
RelB	NULL
or	NULL
p65	NULL
in	NULL
transactivation	NULL
of	NULL
a	NULL
reporter	NULL
plasmid	NULL
dependent	NULL
on	NULL
a	NULL
xB	NULL
site	NULL
.	NULL

The	NULL
data	NULL
imply	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
complex	NULL
family	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
transcription	NULL
factors	NULL
.	NULL

NF-	NULL
«	NULL
kB	NULL
denotes	NULL
a	NULL
transcription	NULL
factor	NULL
which	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
induced	NULL
expression	NULL
of	NULL
many	NULL
genes	NULL
and	NULL
viruses	NULL
(	NULL
for	NULL
reviews	NULL
see	NULL
references	NULL
2	NULL
and	NULL
27	NULL
)	NULL
.	NULL

NF-KB	NULL
is	NULL
presumed	NULL
to	NULL
exert	NULL
its	NULL
effect	NULL
through	NULL
binding	NULL
to	NULL
cis-acting	NULL
,	NULL
so-called	NULL
kB	NULL
elements	NULL
present	NULL
in	NULL
the	NULL
respective	NULL
promoters-enhancers	NULL
.	NULL

The	NULL
original	NULL
kB	NULL
site	NULL
was	NULL
defined	NULL
as	NULL
an	NULL
essential	NULL
functional	NULL
component	NULL
of	NULL
the	NULL
intronic	NULL
immunoglobulin	NULL
light-chain	NULL
enhancer	NULL
,	NULL
and	NULL
its	NULL
decameric	NULL
sequence	NULL
is	NULL
GGGAC	NULL
TTTCC	NULL
(	NULL
the	NULL
«	NULL
kB	NULL
consensus	NULL
sequence	NULL
reads	NULL
GGGRNNY	NULL
YCC	NULL
)	NULL
.	NULL

Included	NULL
among	NULL
the	NULL
NF-	NULL
«	NULL
B-responsive	NULL
genes	NULL
are	NULL
many	NULL
involved	NULL
in	NULL
immune	NULL
responses	NULL
and/or	NULL
acute-phase	NULL
reactions	NULL
,	NULL
such	NULL
as	NULL
the	NULL
cytokines	NULL
interleukin-2	NULL
,	NULL
interleukin-6	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
,	NULL
the	NULL
immunoglobulin	NULL
x	NULL
light	NULL
chain	NULL
,	NULL
and	NULL
angioten-sinogen	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
certain	NULL
viruses	NULL
,	NULL
including	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
and	NULL
cytomegalovirus	NULL
,	NULL
are	NULL
regulated	NULL
in	NULL
their	NULL
expression	NULL
by	NULL
NF-kB	NULL
.	NULL

An	NULL
array	NULL
of	NULL
different	NULL
signals	NULL
targets	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
activate	NULL
gene	NULL
expression	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
,	NULL
phorbol	NULL
esters	NULL
,	NULL
lectins	NULL
,	NULL
interleukin-1	NULL
,	NULL
and	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
product	NULL
,	NULL
for	NULL
example	NULL
,	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
increase	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
in	NULL
cells	NULL
(	NULL
for	NULL
a	NULL
review	NULL
of	NULL
NF-	NULL
«	NULL
kB-regulated	NULL
genes	NULL
,	NULL
binding	NULL
sites	NULL
,	NULL
and	NULL
stimulating	NULL
agents	NULL
of	NULL
NF-kB	NULL
,	NULL
see	NULL
reference	NULL
2	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
cytoplasmic	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
the	NULL
signal-dependent	NULL
release	NULL
from	NULL
an	NULL
inhibitory	NULL
protein	NULL
designated	NULL
IxB	NULL
(	NULL
3	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
phosphorylation	NULL
of	NULL
IxB	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
releases	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
thereby	NULL
allowing	NULL
the	NULL
transcription	NULL
factor	NULL
to	NULL
translo-cate	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
activate	NULL
gene	NULL
expression	NULL
by	NULL
binding	NULL
to	NULL
cis-acting	NULL
regulatory	NULL
DNA	NULL
elements	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Recently	NULL
NF-	NULL
«	NULL
B	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

t	NULL
Present	NULL
address	NULL
:	NULL
Laboratory	NULL
of	NULL
Clinical	NULL
Investigations	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
.	NULL

+	NULL
Permanent	NULL
address	NULL
:	NULL
School	NULL
of	NULL
Biological	NULL
Sciences	NULL
,	NULL
University	NULL
of	NULL
Sydney	NULL
,	NULL
Sydney	NULL
,	NULL
New	NULL
South	NULL
Wales	NULL
2006	NULL
,	NULL
Australia	NULL
.	NULL

685	NULL
has	NULL
been	NULL
recognized	NULL
to	NULL
exist	NULL
as	NULL
a	NULL
heterodimer	NULL
of	NULL
a	NULL
p50	NULL
and	NULL
a	NULL
p65	NULL
subunit	NULL
(	NULL
47	NULL
)	NULL
.	NULL

p50	NULL
can	NULL
form	NULL
homodimers	NULL
,	NULL
but	NULL
it	NULL
is	NULL
the	NULL
heterodimer	NULL
that	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
the	NULL
primary	NULL
transactivating	NULL
complex	NULL
owing	NULL
to	NULL
potentially	NULL
transactivating	NULL
sequences	NULL
present	NULL
in	NULL
p65	NULL
(	NULL
34	NULL
,	NULL
38	NULL
)	NULL
.	NULL

The	NULL
genes	NULL
encoding	NULL
NF-	NULL
«	NULL
B	NULL
have	NULL
recently	NULL
been	NULL
cloned	NULL
.	NULL

p50	NULL
is	NULL
part	NULL
of	NULL
a	NULL
larger	NULL
precursor	NULL
protein	NULL
of	NULL
105	NULL
kDa	NULL
.	NULL

We	NULL
have	NULL
cloned	NULL
this	NULL
gene	NULL
,	NULL
originally	NULL
designated	NULL
243	NULL
,	NULL
as	NULL
a	NULL
mitogen-induced	NULL
cDNA	NULL
selected	NULL
from	NULL
a	NULL
collection	NULL
of	NULL
such	NULL
clones	NULL
which	NULL
harbor	NULL
immediate-early	NULL
response	NULL
genes	NULL
(	NULL
6	NULL
)	NULL
,	NULL
and	NULL
others	NULL
have	NULL
cloned	NULL
this	NULL
gene	NULL
by	NULL
using	NULL
nucleic	NULL
acid	NULL
probes	NULL
based	NULL
on	NULL
partial	NULL
peptide	NULL
sequences	NULL
of	NULL
purified	NULL
p50	NULL
protein	NULL
(	NULL
13	NULL
,	NULL
24	NULL
,	NULL
31	NULL
)	NULL
.	NULL

The	NULL
105-kDa	NULL
precursor	NULL
protein	NULL
consists	NULL
of	NULL
two	NULL
main	NULL
do-mains	NULL
,	NULL
an	NULL
amino-terminal	NULL
region	NULL
of	NULL
about	NULL
300	NULL
amino	NULL
acids	NULL
related	NULL
to	NULL
the	NULL
amino-terminal	NULL
part	NULL
of	NULL
the	NULL
c-Rel	NULL
protein	NULL
(	NULL
7	NULL
)	NULL
and	NULL
a	NULL
carboxy-terminal	NULL
portion	NULL
containing	NULL
several	NULL
so-called	NULL
cell	NULL
cycle	NULL
or	NULL
ankyrin	NULL
repeat	NULL
structures	NULL
.	NULL

The	NULL
carboxy-terminal	NULL
domain	NULL
inhibits	NULL
binding	NULL
of	NULL
the	NULL
precursor	NULL
protein	NULL
to	NULL
DNA	NULL
.	NULL

Upon	NULL
removal	NULL
of	NULL
the	NULL
repeat	NULL
domain	NULL
by	NULL
proteolytic	NULL
cleavage	NULL
,	NULL
the	NULL
amino-terminal	NULL
region	NULL
corresponding	NULL
to	NULL
the	NULL
p50	NULL
protein	NULL
and	NULL
containing	NULL
all	NULL
sequences	NULL
related	NULL
to	NULL
c-Rel	NULL
specifically	NULL
binds	NULL
kB	NULL
DNA	NULL
elements	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
p65	NULL
gene	NULL
also	NULL
encodes	NULL
a	NULL
Rel-related	NULL
protein	NULL
(	NULL
34	NULL
,	NULL
38	NULL
)	NULL
.	NULL

c-Rel	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
p65	NULL
share	NULL
extensive	NULL
homology	NULL
in	NULL
their	NULL
amino-terminal	NULL
regions	NULL
,	NULL
the	NULL
so-called	NULL
Rel	NULL
homology	NULL
domain	NULL
,	NULL
but	NULL
differ	NULL
elsewhere	NULL
.	NULL

c-Rel	NULL
and	NULL
p65	NULL
do	NULL
not	NULL
contain	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
ankyrin	NULL
)	NULL
repeats	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
p50	NULL
and	NULL
p65	NULL
are	NULL
related	NULL
to	NULL
c-Rel	NULL
and	NULL
bind	NULL
«	NULL
B	NULL
sites	NULL
has	NULL
led	NULL
to	NULL
the	NULL
recent	NULL
discovery	NULL
that	NULL
the	NULL
c-rel	NULL
proto-oncogene	NULL
and	NULL
the	NULL
v-rel	NULL
oncogene	NULL
products	NULL
are	NULL
also	NULL
capable	NULL
of	NULL
binding	NULL
kB	NULL
DNA	NULL
.	NULL

However	NULL
,	NULL
only	NULL
c-Rel	NULL
transactivates	NULL
,	NULL
whereas	NULL
v-Rel	NULL
inhibits	NULL
«	NULL
B-dependent	NULL
transcription	NULL
(	NULL
5	NULL
,	NULL
19	NULL
,	NULL
23	NULL
,	NULL
36	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
rel-related	NULL
drosophila	NULL
gene	NULL
product	NULL
,	NULL
Dorsal	NULL
,	NULL
which	NULL
is	NULL
the	NULL
essential	NULL
morphogenic	NULL
determinant	NULL
for	NULL
ventral-dorsal	NULL
polarity	NULL
,	NULL
binds	NULL
to	NULL
sites	NULL
closely	NULL
resembling	NULL
«	NULL
B	NULL
sites	NULL
and	NULL
activates	NULL
gene	NULL
expression	NULL
(	NULL
20	NULL
,	NULL
45	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
a	NULL
family	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
complexes	NULL
which	NULL
together	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
pleiotropic	NULL
cellular	NULL
effects	NULL
originally	NULL
ascribed	NULL
to	NULL
just	NULL
one	NULL
transcription	NULL
factor	NULL
complex	NULL
.	NULL

686	NULL
BOURS	NULL
ET	NULL
AL	NULL
.	NULL

Recently	NULL
the	NULL
IxB-encoding	NULL
gene	NULL
and	NULL
a	NULL
related	NULL
gene	NULL
from	NULL
chicken	NULL
called	NULL
pp40	NULL
have	NULL
been	NULL
cloned	NULL
(	NULL
10	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Both	NULL
proteins	NULL
contain	NULL
cell	NULL
cycle	NULL
(	NULL
ankyrin	NULL
)	NULL
repeats	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
these	NULL
inhibitory	NULL
proteins	NULL
contain	NULL
such	NULL
repeats	NULL
suggests	NULL
that	NULL
the	NULL
repeats	NULL
in	NULL
the	NULL
105-kDa	NULL
p50	NULL
precursor	NULL
protein	NULL
constitute	NULL
a	NULL
built-in	NULL
inhibitor	NULL
of	NULL
this	NULL
protein	NULL
.	NULL

In	NULL
the	NULL
present	NULL
report	NULL
we	NULL
describe	NULL
the	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
gene	NULL
encoding	NULL
a	NULL
kB	NULL
DNA-binding	NULL
activity	NULL
.	NULL

Like	NULL
the	NULL
p50	NULL
precursor	NULL
gene	NULL
(	NULL
p105	NULL
)	NULL
,	NULL
this	NULL
gene	NULL
was	NULL
discovered	NULL
as	NULL
a	NULL
member	NULL
of	NULL
our	NULL
collection	NULL
of	NULL
mitogen-inducible	NULL
cDNA	NULL
clones	NULL
isolated	NULL
from	NULL
activated	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
the	NULL
clone	NULL
was	NULL
originally	NULL
designated	NULL
189	NULL
)	NULL
.	NULL

The	NULL
encoded	NULL
protein	NULL
is	NULL
most	NULL
closely	NULL
related	NULL
to	NULL
the	NULL
p50	NULL
precursor	NULL
(	NULL
p105	NULL
)	NULL
,	NULL
harboring	NULL
a	NULL
Rel	NULL
homology	NULL
domain	NULL
and	NULL
a	NULL
cell	NULL
cycle	NULL
(	NULL
ankyrin	NULL
)	NULL
repeat	NULL
domain	NULL
.	NULL

By	NULL
analogy	NULL
with	NULL
the	NULL
processed	NULL
and	NULL
full-length	NULL
protein	NULL
of	NULL
p50/p105	NULL
,	NULL
we	NULL
refer	NULL
to	NULL
the	NULL
products	NULL
of	NULL
this	NULL
novel	NULL
gene	NULL
as	NULL
p50B/p97	NULL
.	NULL

p50B	NULL
can	NULL
form	NULL
a	NULL
previously	NULL
unrecognized	NULL
heteromeric	NULL
<	NULL
B-binding	NULL
complex	NULL
with	NULL
the	NULL
newly	NULL
described	NULL
mouse	NULL
Rel	NULL
homolog	NULL
,	NULL
ReIB	NULL
(	NULL
39	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
is	NULL
distinct	NULL
from	NULL
any	NULL
previously	NULL
described	NULL
NF-KB	NULL
factor	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
a	NULL
complex	NULL
family	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
transcription	NULL
factors	NULL
exists	NULL
in	NULL
vivo	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
RNA	NULL
analysis	NULL
.	NULL

Purification	NULL
of	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
,	NULL
extraction	NULL
of	NULL
RNA	NULL
,	NULL
fractionation	NULL
on	NULL
agarose-formaldehyde	NULL
gels	NULL
,	NULL
and	NULL
hybridization	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
,	NULL
50	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
phytohemagglutinin	NULL
(	NULL
1	NULL
pg/ml	NULL
!	NULL
)	NULL

and	NULL
phorbol-12-myristate-13-acetate	NULL
(	NULL
25	NULL
ng/ml	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
cycloheximide	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
sequence	NULL
lay	NULL
between	NULL
nucleotides	NULL
688	NULL
and	NULL
3113	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

DNA	NULL
sequencing	NULL
.	NULL

Nucleotide	NULL
sequencing	NULL
was	NULL
performed	NULL
by	NULL
the	NULL
dideoxy-chain	NULL
termination	NULL
method	NULL
(	NULL
Sequenase	NULL
;	NULL
U.S.	NULL
Biochemical	NULL
Corp.	NULL
)	NULL
as	NULL
specified	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Both	NULL
strands	NULL
of	NULL
several	NULL
overlapping	NULL
cDNA	NULL
clones	NULL
were	NULL
se-quenced	NULL
.	NULL

Computer	NULL
analysis	NULL
.	NULL

Computer	NULL
searches	NULL
were	NULL
performed	NULL
at	NULL
the	NULL
National	NULL
Center	NULL
for	NULL
Biotechnology	NULL
Information	NULL
by	NULL
using	NULL
the	NULL
Blast	NULL
Network	NULL
Service	NULL
and	NULL
the	NULL
FASTA	NULL
and	NULL
FASTP	NULL
programs	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
used	NULL
the	NULL
PCGENE	NULL
programs	NULL
.	NULL

TAG	NULL
constructs	NULL
.	NULL

The	NULL
pMR-TAG	NULL
plasmid	NULL
(	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Mitchell	NULL
Rosner	NULL
)	NULL
is	NULL
a	NULL
derivative	NULL
of	NULL
pSP64	NULL
into	NULL
which	NULL
a	NULL
TAG	NULL
epitope-encoding	NULL
DNA	NULL
segment	NULL
was	NULL
inserted	NULL
downstream	NULL
of	NULL
the	NULL
SP6	NULL
promoter	NULL
.	NULL

This	NULL
DNA	NULL
segment	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
one	NULL
present	NULL
in	NULL
the	NULL
vector	NULL
pCGN	NULL
(	NULL
44	NULL
)	NULL
:	NULL
it	NULL
contains	NULL
a	NULL
herpes	NULL
simplex	NULL
virus	NULL
k	NULL
leader	NULL
sequence/ATG	NULL
followed	NULL
by	NULL
the	NULL
sequence	NULL
ASSYPYDVPDYASLGGPSR	NULL
,	NULL
encoding	NULL
in	NULL
part	NULL
the	NULL
TAG	NULL
epitope	NULL
derived	NULL
from	NULL
influenza	NULL
virus	NULL
hemag-glutinin	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
last	NULL
two	NULL
amino	NULL
acids	NULL
are	NULL
encoded	NULL
by	NULL
an	NULL
Xbal	NULL
cloning	NULL
site	NULL
which	NULL
is	NULL
followed	NULL
by	NULL
a	NULL
polylinker	NULL
cloning	NULL
region	NULL
.	NULL

By	NULL
using	NULL
polymerase	NULL
chain	NULL
reaction-generated	NULL
clones	NULL
of	NULL
p50B/p97	NULL
into	NULL
which	NULL
convenient	NULL
restriction	NULL
enzyme	NULL
sites	NULL
were	NULL
inserted	NULL
as	NULL
part	NULL
of	NULL
primers	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
initiating	NULL
methionine	NULL
,	NULL
p50B/p97	NULL
was	NULL
cloned	NULL
in	NULL
frame	NULL
downstream	NULL
of	NULL
the	NULL
TAG	NULL
epitope	NULL
.	NULL

Two	NULL
constructs	NULL
were	NULL
generated	NULL
:	NULL
pMR-TAGpS50B	NULL
(	NULL
truncated	NULL
at	NULL
the	NULL
Sacl	NULL
site	NULL
[	NULL
see	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
,	NULL
used	NULL
in	NULL
the	NULL
experiments	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
4A	NULL
,	NULL
and	NULL
4B	NULL
)	NULL
and	NULL
pMR-TAGp97	NULL
(	NULL
used	NULL
in	NULL
the	NULL
experiments	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
3D	NULL
,	NULL
4C	NULL
,	NULL
5	NULL
,	NULL
and	NULL
7	NULL
)	NULL
;	NULL
these	NULL
constructions	NULL
added	NULL
the	NULL
codons	NULL
for	NULL
the	NULL
amino	NULL
acids	NULL
QFTRVDPRSAAA	NULL
(	NULL
for	NULL
the	NULL
pMR-TAGpS0B	NULL
construct	NULL
)	NULL
or	NULL
QF	NULL
(	NULL
for	NULL
the	NULL
pMR-TAGp97	NULL
construct	NULL
)	NULL
between	NULL
the	NULL
end	NULL
of	NULL
the	NULL
epitope	NULL
sequence	NULL
and	NULL
the	NULL
original	NULL
ATG	NULL
initiator	NULL
codon	NULL
of	NULL
pSOB/p97	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
total	NULL
addition	NULL
of	NULL
32	NULL
and	NULL
22	NULL
amino	NULL
acids	NULL
to	NULL
the	NULL
encoded	NULL
proteins	NULL
,	NULL
respectively	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

The	NULL
p50	NULL
gene	NULL
(	NULL
clone	NULL
243	NULL
truncated	NULL
at	NULL
the	NULL
Rsal	NULL
site	NULL
)	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
same	NULL
pMR-TAG	NULL
vector	NULL
by	NULL
using	NULL
the	NULL
BamHI	NULL
site	NULL
present	NULL
at	NULL
nucleotide	NULL
260	NULL
(	NULL
6	NULL
)	NULL
,	NULL
inserting	NULL
the	NULL
amino	NULL
acids	NULL
QFTRV	NULL
between	NULL
the	NULL
epitope	NULL
and	NULL
the	NULL
p50	NULL
sequence	NULL
(	NULL
con-struct	NULL
pMR-TAG	NULL
p50	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction-generated	NULL
clones	NULL
were	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
,	NULL
as	NULL
were	NULL
the	NULL
cloning	NULL
junctions	NULL
of	NULL
all	NULL
constructs	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
.	NULL

An	NULL
8-ug	NULL
portion	NULL
of	NULL
the	NULL
pMR-TAG	NULL
or	NULL
Bluescript	NULL
(	NULL
Stratagene	NULL
)	NULL
vector	NULL
bearing	NULL
the	NULL
gene	NULL
of	NULL
interest	NULL
was	NULL
linearized	NULL
with	NULL
the	NULL
appropriate	NULL
enzyme	NULL
and	NULL
used	NULL
as	NULL
a	NULL
template	NULL
for	NULL
in	NULL
vitro	NULL
transcription	NULL
with	NULL
T3	NULL
,	NULL
T7	NULL
(	NULL
Stratagene	NULL
)	NULL
,	NULL
or	NULL
SP6	NULL
(	NULL
Promega	NULL
)	NULL
polymerase	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

After	NULL
phenol-chloroform	NULL
extraction	NULL
and	NULL
ethanol	NULL
precipitation	NULL
,	NULL
the	NULL
RNA	NULL
was	NULL
resuspended	NULL
in	NULL
100	NULL
pt	NULL
of	NULL
diethyl	NULL
pyrocarbonate-treated	NULL
water	NULL
.	NULL

Then	NULL
0.5	NULL
to	NULL
2	NULL
wl	NULL
of	NULL
this	NULL
solution	NULL
was	NULL
used	NULL
to	NULL
direct	NULL
in	NULL
vitro	NULL
translation	NULL
with	NULL
wheat	NULL
germ	NULL
extract	NULL
or	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

To	NULL
obtain	NULL
heteromeric	NULL
complexes	NULL
between	NULL
two	NULL
different	NULL
proteins	NULL
,	NULL
we	NULL
routinely	NULL
cotranslated	NULL
their	NULL
RNAs	NULL
since	NULL
mixing	NULL
of	NULL
separate	NULL
translation	NULL
products	NULL
resulted	NULL
in	NULL
weaker	NULL
associa-tions	NULL
.	NULL

The	NULL
Bluescript	NULL
plasmids	NULL
used	NULL
for	NULL
the	NULL
translations	NULL
included	NULL
those	NULL
encoding	NULL
human	NULL
p65	NULL
(	NULL
38	NULL
)	NULL
,	NULL
RelB	NULL
(	NULL
39	NULL
)	NULL
,	NULL
human	NULL
p50	NULL
(	NULL
the	NULL
243	NULL
gene	NULL
encoding	NULL
the	NULL
precursor	NULL
was	NULL
truncated	NULL
at	NULL
the	NULL
Rsal	NULL
site	NULL
and	NULL
cloned	NULL
separately	NULL
into	NULL
the	NULL
Smal	NULL
site	NULL
of	NULL
Bluescript	NULL
[	NULL
6	NULL
]	NULL
)	NULL
,	NULL
and	NULL
a	NULL
pS50B/p97	NULL
construct	NULL
.	NULL

The	NULL
p50B/p97	NULL
construct	NULL
contained	NULL
a	NULL
polymerase	NULL
chain	NULL
reaction-generated	NULL
I-nucleo-tide	NULL
leader	NULL
sequence	NULL
(	NULL
GCCGCCGCC	NULL
)	NULL
downstream	NULL
of	NULL
a	NULL
BamH	NULL
]	NULL
site	NULL
and	NULL
upstream	NULL
of	NULL
the	NULL
ATG	NULL
initiator	NULL
to	NULL
facilitate	NULL
in	NULL
vitro	NULL
translations	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
used	NULL
the	NULL
pMR-TAGp50B	NULL
,	NULL
pMR-TAGp97	NULL
,	NULL
and	NULL
pMR-TAGpS0	NULL
constructs	NULL
described	NULL
above	NULL
.	NULL

EMSA	NULL
.	NULL

Double-stranded	NULL
oligonucleotide	NULL
probes	NULL
were	NULL
prepared	NULL
for	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
by	NULL
annealing	NULL
the	NULL
appropriate	NULL
single-stranded	NULL
oligonucleotides	NULL
at	NULL
65°C	NULL
for	NULL
10	NULL
min	NULL
in	NULL
10	NULL
mM	NULL
Tris-1	NULL
mM	NULL
EDTA-10	NULL
mM	NULL
NaCl	NULL
followed	NULL
by	NULL
slow	NULL
cooling	NULL
to	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
probes	NULL
were	NULL
end	NULL
labeled	NULL
with	NULL
P-labeled	NULL
ATP	NULL
,	NULL
GTP	NULL
,	NULL
CTP	NULL
,	NULL
and	NULL
TTP	NULL
by	NULL
filling	NULL
in	NULL
5°	NULL
overhangs	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
.	NULL

The	NULL
oligonucleotides	NULL
used	NULL
were	NULL
as	NULL
follows	NULL
.	NULL

palindromic	NULL
«	NULL
B	NULL
probe	NULL
(	NULL
PD-	NULL
«	NULL
B	NULL
)	NULL
(	NULL
5	NULL
)	NULL
wild	NULL
type	NULL
5	NULL
``	NULL
-GATCCAACGGCAGGGGAATTCCCCTCTCCTTA	NULL
CTTGCCCTCCCCTTAAGGGGAGAGGAATCTAG-5	NULL
'	NULL
and	NULL
5'-GATCCAACCGCAGATCTATTCCCCTCTCCTTA	NULL
CTTGCCGTCTAGCATAACCCGAGAGGAATCTAG-S	NULL
'	NULL
HIV	NULL
kB	NULL
probe	NULL
(	NULL
32	NULL
)	NULL
wild	NULL
type	NULL
5	NULL
``	NULL
-GATCAGGGACTTTCCGCTGGGGACTTTCCAG	NULL
TCCCTGAAAGGCGACCCCTGAAAGGTCCTAG-5	NULL
'	NULL
and	NULL
5-GATCACTCACTTTCCGCTGCTCACTTTCCAG	NULL
TGAGTGAAAGCCGACCAGTGAAAGCTCCTAG-S	NULL
'	NULL
mutant	NULL
mutant	NULL
One	NULL
to	NULL
three	NULL
microliters	NULL
of	NULL
the	NULL
in	NULL
vitro-translated	NULL
product	NULL
(	NULL
wheat	NULL
germ	NULL
extract	NULL
)	NULL
was	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
in	NULL
a	NULL
solution	NULL
containing	NULL
the	NULL
incubation	NULL
buffer	NULL
,	NULL
0.5	NULL
to	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
and	NULL
0.2	NULL
ng	NULL
of	NULL
the	NULL
labeled	NULL
probe	NULL
(	NULL
100,000	NULL
cpm	NULL
)	NULL
.	NULL

The	NULL
incubation	NULL
buffer	NULL
was	NULL
either	NULL
the	NULL
buffer	NULL
from	NULL
the	NULL
Stratagene	NULL
Gelshift	NULL
kit	NULL
or	NULL
buffer	NULL
B	NULL
(	NULL
20	NULL
mM	NULL
-	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
[	NULL
HEPES	NULL
]	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
MgC1	NULL
;	NULL
,	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
.	NULL

Competition	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
30-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
.	NULL

For	NULL
supershifts	NULL
with	NULL
antibodies	NULL
,	NULL
the	NULL
in	NULL
vitro-translated	NULL
proteins	NULL
and	NULL
the	NULL
antibody	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
in	NULL
incubation	NULL
buffer	NULL
plus	NULL
poly	NULL
(	NULL
dl-dC	NULL
)	NULL
before	NULL
the	NULL
probe	NULL
was	NULL
added	NULL
.	NULL

Either	NULL
an	NULL
anti-TAG	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Berkeley	NULL
Antibody	NULL
Co.	NULL
)	NULL
or	NULL
an	NULL
anti-ReIB	NULL
polyclonal	NULL
antibody	NULL
was	NULL
used	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
separated	NULL
on	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
run	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
0.25	NULL
%	NULL
Tris-borate-EDTA	NULL
(	NULL
TBE	NULL
)	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Stability	NULL
assays	NULL
.	NULL

The	NULL
in	NULL
vitro-translated	NULL
products	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
probe	NULL
with	NULL
or	NULL
without	NULL
GTP	NULL
as	NULL
described	NULL
.	NULL

After	NULL
30	NULL
min	NULL
of	NULL
incubation	NULL
,	NULL
a	NULL
sample	NULL
was	NULL
removed	NULL
and	NULL
loaded	NULL
on	NULL
a	NULL
gel	NULL
(	NULL
time	NULL
zero	NULL
)	NULL
and	NULL
a	NULL
500-	NULL
to	NULL
1,000-fold	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
probe	NULL
was	NULL
added	NULL
.	NULL

Subsequently	NULL
aliquots	NULL
were	NULL
removed	NULL
and	NULL
loaded	NULL
onto	NULL
a	NULL
continuously	NULL
running	NULL
gel	NULL
(	NULL
4°C	NULL
)	NULL
at	NULL
the	NULL
times	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

This	NULL
experimental	NULL
design	NULL
ensured	NULL
a	NULL
minimum	NULL
of	NULL
experimental	NULL
variation	NULL
.	NULL

Immunoprecipitations	NULL
.	NULL

Immunoprecipitations	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
accompanying	NULL
paper	NULL
by	NULL
Ryseck	NULL
et	NULL
al	NULL
.	NULL

(	NULL
39	NULL
)	NULL
.	NULL

A	NULL
6-ul	NULL
portion	NULL
of	NULL
each	NULL
[	NULL
**SJmethionine-labeled	NULL
translation	NULL
(	NULL
Promega	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
system	NULL
)	NULL
was	NULL
added	NULL
to	NULL
0.6	NULL
ml	NULL
of	NULL
RIPA	NULL
buffer	NULL
without	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
.	NULL

Then	NULL
1.5	NULL
pl	NULL
of	NULL
RelB	NULL
polyclonal	NULL
antibody	NULL
was	NULL
added	NULL
and	NULL
mixed	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
allowed	NULL
to	NULL
stand	NULL
on	NULL
ice	NULL
for	NULL
2	NULL
h.	NULL
Ten	NULL
microliters	NULL
of	NULL
a	NULL
1:1	NULL
slurry	NULL
of	NULL
protein	NULL
A-Sepharose	NULL
(	NULL
Pharmacia	NULL
)	NULL
in	NULL
RIPA	NULL
buffer	NULL
without	NULL
SDS	NULL
was	NULL
added	NULL
and	NULL
mixed	NULL
on	NULL
a	NULL
rotator	NULL
at	NULL
4°C	NULL
for	NULL
2	NULL
h.	NULL
The	NULL
protein	NULL
A-Sepharose	NULL
plus	NULL
the	NULL
antibody	NULL
complex	NULL
was	NULL
then	NULL
recovered	NULL
by	NULL
centrifugation	NULL
;	NULL
washed	NULL
in	NULL
succession	NULL
with	NULL
0.6	NULL
ml	NULL
of	NULL
buffers	NULL
A	NULL
(	NULL
twice	NULL
)	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
;	NULL
resuspended	NULL
in	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
;	NULL
boiled	NULL
in	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
;	NULL
and	NULL
electro-phoresed	NULL
on	NULL
an	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
gel	NULL
(	NULL
10	NULL
%	NULL
acrylamide	NULL
)	NULL
.	NULL

Buffer	NULL
compositions	NULL
are	NULL
given	NULL
in	NULL
the	NULL
accompanying	NULL
paper	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Expression	NULL
vectors	NULL
and	NULL
reporter	NULL
plasmid	NULL
.	NULL

re/iB	NULL
,	NULL
p65	NULL
,	NULL
p50	NULL
(	NULL
truncated	NULL
at	NULL
the	NULL
Xbal	NULL
site	NULL
)	NULL
,	NULL
and	NULL
p50B	NULL
(	NULL
truncated	NULL
at	NULL
the	NULL
Xhol	NULL
site	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

3A	NULL
for	NULL
a	NULL
map	NULL
of	NULL
the	NULL
truncations	NULL
)	NULL
were	NULL
cloned	NULL
in	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
the	NULL
PMT2T	NULL
expression	NULL
vector	NULL
(	NULL
22	NULL
)	NULL
.	NULL

This	NULL
plasmid	NULL
contains	NULL
an	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
,	NULL
a	NULL
simian	NULL
virus	NULL
40	NULL
enhancer	NULL
,	NULL
and	NULL
a	NULL
simian	NULL
virus	NULL
40	NULL
polyadenylation	NULL
site	NULL
.	NULL

The	NULL
reporter	NULL
plasmid	NULL
,	NULL
HIV-	NULL
«	NULL
B	NULL
CAT	NULL
,	NULL
has	NULL
a	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
driven	NULL
by	NULL
a	NULL
minimal	NULL
c-fos	NULL
promoter	NULL
which	NULL
contains	NULL
the	NULL
two	NULL
kB	NULL
sites	NULL
from	NULL
the	NULL
HIV	NULL
enhancer	NULL
inserted	NULL
at	NULL
the	NULL
Sall	NULL
site	NULL
at	NULL
-56	NULL
(	NULL
14	NULL
,	NULL
26	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Another	NULL
version	NULL
of	NULL
this	NULL
construct	NULL
containing	NULL
two	NULL
mutant	NULL
kB	NULL
sites	NULL
was	NULL
used	NULL
also	NULL
(	NULL
J32	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
cell	NULL
lines	NULL
and	NULL
CAT	NULL
assay	NULL
.	NULL

Two	NULL
million	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
0.03	NULL
to	NULL
3	NULL
ug	NULL
of	NULL
each	NULL
expression	NULL
plasmid	NULL
and	NULL
6	NULL
pg	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
diluted	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
0.25	NULL
M	NULL
CaCl	NULL
,	NULL
,	NULL
mixed	NULL
with	NULL
0.5	NULL
ml	NULL
of	NULL
2x	NULL
BBS	NULL
(	NULL
BES-buffered	NULL
saline	NULL
)	NULL
,	NULL
and	NULL
then	NULL
added	NULL
to	NULL
the	NULL
medium	NULL
[	NULL
2x	NULL
BBS	NULL
buffer	NULL
is	NULL
50	NULL
mM	NULL
N	NULL
,	NULL
N-bis	NULL
(	NULL
2	NULL
hydroxyethyl	NULL
)	NULL
-2-ami-noethanosulfonic	NULL
acid	NULL
(	NULL
BES	NULL
;	NULL
pH	NULL
6.96	NULL
)	NULL
containing	NULL
280	NULL
mM	NULL
NaCl	NULL
and	NULL
1.5	NULL
mM	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
]	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
14	NULL
to	NULL
16	NULL
h	NULL
at	NULL
37°C	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
incubated	NULL
further	NULL
for	NULL
24	NULL
h	NULL
before	NULL
being	NULL
harvested	NULL
and	NULL
lysed	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
heated	NULL
at	NULL
70°C	NULL
for	NULL
10	NULL
min	NULL
and	NULL
incubated	NULL
in	NULL
a	NULL
scintillation	NULL
vial	NULL
with	NULL
a	NULL
freshly	NULL
prepared	NULL
solution	NULL
of	NULL
chloramphenicol	NULL
(	NULL
3	NULL
mg/ml	NULL
)	NULL
and	NULL
[	NULL
*HJacetyl	NULL
coen-zyme	NULL
A	NULL
(	NULL
200,000	NULL
cpm	NULL
)	NULL
in	NULL
0.1	NULL
M	NULL
Tris	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
was	NULL
gently	NULL
overlaid	NULL
with	NULL
3	NULL
ml	NULL
of	NULL
Econofluor	NULL
(	NULL
Du	NULL
Pont	NULL
)	NULL
(	NULL
33	NULL
)	NULL
.	NULL

The	NULL
scintillation	NULL
vials	NULL
were	NULL
counted	NULL
at	NULL
selected	NULL
time	NULL
intervals	NULL
.	NULL

RESULTS	NULL
Cloning	NULL
and	NULL
sequence	NULL
of	NULL
the	NULL
cDNA	NULL
encoding	NULL
p50B/p97	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
constructed	NULL
a	NULL
subtractive	NULL
cDNA	NULL
library	NULL
from	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
which	NULL
was	NULL
enriched	NULL
for	NULL
mitogen-inducible	NULL
genes	NULL
.	NULL

Screening	NULL
of	NULL
this	NULL
library	NULL
with	NULL
a	NULL
subtracted	NULL
probe	NULL
,	NULL
again	NULL
enriched	NULL
for	NULL
genes	NULL
activated	NULL
early	NULL
after	NULL
mitogenic	NULL
stimulation	NULL
,	NULL
yielded	NULL
more	NULL
than	NULL
60	NULL
distinct	NULL
cDNAs	NULL
(	NULL
21	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Most	NULL
of	NULL
these	NULL
clones	NULL
were	NULL
determined	NULL
to	NULL
be	NULL
novel	NULL
P50B/p97	NULL
,	NULL
A	NULL
NEW	NULL
PROTEIN	NULL
RELATED	NULL
TO	NULL
r50/p105-NF-	NULL
«	NULL
B	NULL
687	NULL
PHA	NULL
+	NULL
PMA	NULL
PHA	NULL
+	NULL
PMA	NULL
+	NULL
CHX	NULL
|	NULL
351	NULL
I	NULL
e	NULL
&	NULL
®	NULL
&	NULL
OQ	NULL
‘	NULL
\~Z	NULL
‘	NULL
fl	NULL
?	NULL
)	NULL

Dr	NULL
}	NULL
(	NULL
ab	NULL
G	NULL
\\Z	NULL
‘	NULL
(	NULL
L	NULL
?	NULL
)	NULL

D	NULL
‘	NULL
Z	NULL
‘	NULL
tb	NULL
‘	NULL
Z	NULL
‘	NULL
o	NULL
``	NULL
O	NULL
®	NULL
«	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Induction	NULL
of	NULL
p50/p97	NULL
mRNA	NULL
.	NULL

Peripheral	NULL
blood	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
phorbol-12-myristate	NULL
l3-acetate	NULL
(	NULL
PMA	NULL
)	NULL
and	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
extracted	NULL
at	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

Roughly	NULL
equivalent	NULL
amounts	NULL
of	NULL
RNA	NULL
were	NULL
loaded	NULL
in	NULL
each	NULL
lane	NULL
as	NULL
confirmed	NULL
by	NULL
hybridization	NULL
with	NULL
a	NULL
B	NULL
;	NULL
-microglobulin	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
note	NULL
that	NULL
the	NULL
size	NULL
of	NULL
the	NULL
mRNA	NULL
decreases	NULL
slightly	NULL
with	NULL
time	NULL
,	NULL
possibly	NULL
reflecting	NULL
a	NULL
progressive	NULL
loss	NULL
of	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tract	NULL
.	NULL

genes	NULL
,	NULL
and	NULL
among	NULL
them	NULL
were	NULL
a	NULL
number	NULL
of	NULL
putative	NULL
transcriptional	NULL
regulatory	NULL
proteins	NULL
(	NULL
6	NULL
,	NULL
49	NULL
;	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Recently	NULL
we	NULL
reported	NULL
the	NULL
characterization	NULL
of	NULL
one	NULL
of	NULL
these	NULL
mitogen-induced	NULL
genes	NULL
,	NULL
clone	NULL
243	NULL
,	NULL
encoding	NULL
a	NULL
c-Rel-related	NULL
protein	NULL
(	NULL
6	NULL
)	NULL
;	NULL
243	NULL
encodes	NULL
the	NULL
105-kDa	NULL
precursor	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
complex	NULL
(	NULL
13	NULL
,	NULL
24	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
an	NULL
additional	NULL
mitogen-induced	NULL
clone	NULL
designated	NULL
189	NULL
has	NULL
now	NULL
revealed	NULL
a	NULL
novel	NULL
distinct	NULL
re/-related	NULL
gene	NULL
.	NULL

We	NULL
will	NULL
refer	NULL
to	NULL
the	NULL
products	NULL
of	NULL
this	NULL
gene	NULL
as	NULL
p50B/p97	NULL
by	NULL
analogy	NULL
with	NULL
p50/p105-NF-	NULL
«	NULL
B	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Northern	NULL
(	NULL
RNA	NULL
)	NULL
blot	NULL
analyses	NULL
showed	NULL
that	NULL
the	NULL
p50B/p97	NULL
mRNA	NULL
induction	NULL
in	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
closely	NULL
mirrored	NULL
that	NULL
of	NULL
p50/p105-NF-	NULL
«	NULL
B	NULL
(	NULL
clone	NULL
243	NULL
)	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
approximately	NULL
3,300-nucleotide	NULL
mRNA	NULL
appeared	NULL
first	NULL
between	NULL
1	NULL
and	NULL
2.5	NULL
h	NULL
after	NULL
stimulation	NULL
of	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
with	NULL
phytohemagglutinin	NULL
and	NULL
phorbol-12-myristate-13-acetate	NULL
;	NULL
it	NULL
exhibited	NULL
prolonged	NULL
induction	NULL
beyond	NULL
16	NULL
h	NULL
,	NULL
although	NULL
the	NULL
level	NULL
began	NULL
to	NULL
decline	NULL
after	NULL
4	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
cycloheximide	NULL
superinduced	NULL
the	NULL
mRNA	NULL
as	NULL
is	NULL
the	NULL
case	NULL
for	NULL
many	NULL
genes	NULL
activated	NULL
early	NULL
by	NULL
mitogens	NULL
(	NULL
50	NULL
)	NULL
.	NULL

pS50B/p97	NULL
mRNA	NULL
was	NULL
also	NULL
inducible	NULL
in	NULL
other	NULL
cells	NULL
,	NULL
including	NULL
human	NULL
peripheral	NULL
blood	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
Jurkat	NULL
and	NULL
CEM	NULL
T	NULL
cell	NULL
lines	NULL
,	NULL
mouse	NULL
bone	NULL
marrow-derived	NULL
mast	NULL
cells	NULL
,	NULL
and	NULL
normal	NULL
human	NULL
lung	NULL
fibroblasts	NULL
stimulated	NULL
with	NULL
serum	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
p50B/p97	NULL
cDNA	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
.	NULL

Its	NULL
size	NULL
is	NULL
close	NULL
to	NULL
the	NULL
estimated	NULL
length	NULL
of	NULL
the	NULL
mRNA	NULL
.	NULL

Several	NULL
different	NULL
cDNAs	NULL
were	NULL
isolated	NULL
and	NULL
analyzed	NULL
to	NULL
obtain	NULL
the	NULL
sequence	NULL
.	NULL

An	NULL
ATG	NULL
conforming	NULL
to	NULL
the	NULL
Kozak	NULL
consensus	NULL
rules	NULL
(	NULL
25	NULL
)	NULL
is	NULL
found	NULL
at	NULL
nucleotide	NULL
251	NULL
,	NULL
at	NULL
the	NULL
beginning	NULL
of	NULL
a	NULL
large	NULL
open	NULL
reading	NULL
frame	NULL
encoding	NULL
a	NULL
900-amino-acid	NULL
polypeptide	NULL
(	NULL
molecular	NULL
mass	NULL
,	NULL
96.8	NULL
kDa	NULL
)	NULL
.	NULL

There	NULL
are	NULL
several	NULL
in-frame	NULL
and	NULL
out-of-frame	NULL
stop	NULL
codons	NULL
preceding	NULL
the	NULL
ATG	NULL
at	NULL
nucleotide	NULL
251	NULL
.	NULL

A	NULL
polyadenylation	NULL
signal	NULL
is	NULL
present	NULL
at	NULL
position	NULL
3055	NULL
.	NULL

The	NULL
predicted	NULL
polypeptide	NULL
encoded	NULL
has	NULL
extensive	NULL
homology	NULL
with	NULL
other	NULL
Rel-related	NULL
proteins	NULL
in	NULL
its	NULL
amino-terminal	NULL
half	NULL
(	NULL
6	NULL
,	NULL
7	NULL
,	NULL
9	NULL
,	NULL
13	NULL
,	NULL
16	NULL
,	NULL
24	NULL
,	NULL
31	NULL
,	NULL
34	NULL
,	NULL
38	NULL
,	NULL
42	NULL
,	NULL
43	NULL
,	NULL
48	NULL
)	NULL
and	NULL
contains	NULL
in	NULL
its	NULL
carboxy-terminal	NULL
half	NULL
six	NULL
to	NULL
seven	NULL
cell	NULL
cycle	NULL
(	NULL
ankyrin	NULL
)	NULL
re	NULL
688	NULL
BOURS	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
144	NULL
®	NULL
v	NULL
b	NULL
bor	NULL
K	NULL
L	NULL
#	NULL
$	NULL
8	NULL
I	NULL
v	NULL
&	NULL
B	NULL
K	NULL
&	NULL
P	NULL
A	NULL
POR	NULL
f	NULL
A	NULL
b	NULL
G	NULL
0	NULL
37	NULL
Lov	NULL
If	NULL
V	NULL
®	NULL
Q	NULL
P	NULL
K	NULL
Q	NULL
R	NULL
G	NULL
r	NULL
R	NULL
r	NULL
R	NULL
v	NULL
G	NULL
Cok	NULL
G	NULL
r	NULL
s	NULL
61	NULL
l	NULL
>	NULL
ﬂl~lm	NULL
@	NULL
G	NULL
c	NULL
L	NULL
P	NULL
G	NULL
A	NULL
§	NULL
s	NULL
®	NULL
K	NULL
G	NULL
R	NULL
K	NULL
f	NULL
v	NULL
Por	NULL
v	NULL
ok	NULL
fo	NULL
cow	NULL
vo	NULL
65	NULL
E	NULL
G	NULL
F	NULL
A	NULL
K	NULL
I	NULL
%	NULL
V	NULL
b	NULL
L	NULL
V	NULL
t	NULL
%	NULL
S	NULL
b	NULL
P	NULL
P	NULL
ROA	NULL
B	NULL
aA	NULL
®	NULL
s	NULL
L	NULL
109	NULL
r	NULL
v	NULL
G	NULL
x	NULL
g	NULL
cos	NULL
&	NULL
L	NULL
G	NULL
I	NULL
C	NULL
A	NULL
v	NULL
s	NULL
v	NULL
G	NULL
P	NULL
K	NULL
b	NULL
MoT	NULL
A	NULL
q	NULL
r	NULL
133	NULL
T	NULL
TGACAAGGT	NULL
I	NULL
$	NULL
R	NULL
M	NULL
D	NULL
K	NULL
f	NULL
A	NULL
G	NULL
s	NULL
v	NULL
R	NULL
G	NULL
G	NULL
b	NULL
x	NULL
v	NULL
¥	NULL
L	NULL
LP	NULL
C	NULL
b	NULL
k	NULL
v	NULL
QKDDIIVIIYIDDllcﬂﬂlicbl	NULL
‘	NULL
S	NULL
tarot	NULL
TGAGCG	NULL
1152	NULL
¥	NULL
A	NULL
I	NULL
V	NULL
F	NULL
R	NULL
f	NULL
R	NULL
P	NULL
oY	NULL
B	NULL
K	NULL
M	NULL
K	NULL
I	NULL
%	NULL
®	NULL
301	NULL
op	NULL
o	NULL
E	NULL
®	NULL
Pov	NULL
f	NULL
vor	NULL
%	NULL
R	NULL
K	NULL
R	NULL
G	NULL
G	NULL
b	NULL
V	NULL
s	NULL
D	NULL
S	NULL
K	NULL
Q	NULL
r	NULL
f	NULL
¥	NULL
325	NULL
Y	NULL
P	NULL
L	NULL
v	NULL
&	NULL
b	NULL
E	NULL
E	NULL
V	NULL
Q	NULL
R	NULL
K	NULL
R	NULL
R	NULL
K	NULL
A	NULL
LOB	NULL
Tor	NULL
s	NULL
q	NULL
oP	NULL
REL	NULL
Homology	NULL
¥	NULL
G	NULL
G	NULL
G	NULL
s	NULL
m	NULL
m	NULL
c	NULL
G	NULL
c	NULL
s	NULL
c	NULL
G	NULL
a	NULL
a	NULL
G	NULL
c	NULL
v	NULL
c	NULL
c	NULL
a	NULL
c	NULL
c	NULL
c	NULL
373	NULL
-	NULL
>	NULL
@	NULL
lycine-cich	NULL
Start	NULL
T	NULL
440	NULL
G	NULL
§	NULL
L	NULL
G	NULL
r	NULL
r	NULL
Pos	NULL
s	NULL
L	NULL
A	NULL
x	NULL
s	NULL
Pox	NULL
q	NULL
s	NULL
G	NULL
A	NULL
G	NULL
P	NULL
M	NULL
G	NULL
C	NULL
397	NULL
$	NULL
12	NULL
421	NULL
x	NULL
®	NULL
G	NULL
G	NULL
a	NULL
c	NULL
c	NULL
a	NULL
v	NULL
R	NULL
s	NULL
R	NULL
Ob	NULL
$	NULL
G	NULL
E	NULL
E	NULL
A	NULL
A	NULL
(	NULL
Janina-nah	NULL
”	NULL
1584	NULL
E	NULL
P	NULL
S	NULL
A	NULL
P	NULL
8s	NULL
R	NULL
t	NULL
P	NULL
Q	NULL
C	NULL
b	NULL
A	NULL
Q	NULL
A	NULL
BoR	NULL
MOL	NULL
Q	NULL
R	NULL
A	NULL
R	NULL
:	NULL
445	NULL
x	NULL
W	NULL
A	NULL
ROL	NULL
F	NULL
G	NULL
L	NULL
A	NULL
Q	NULL
R	NULL
$	NULL
s	NULL
A	NULL
R	NULL
OA	NULL
LOL	NULL
b	NULL
%	NULL
G	NULL
v	NULL
T	NULL
aA	NULL
b	NULL
46	NULL
cc	NULL
1720	NULL
®	NULL
80	NULL
%	NULL
H	NULL
p	NULL
E	NULL
b	NULL
f	NULL
FPL	NULL
®	NULL
493	NULL
[	NULL
7	NULL
®	NULL
1800	NULL
_L	NULL
I	NULL
#	NULL
G	NULL
9	NULL
f	NULL
$	NULL
s	NULL
v	NULL
r	NULL
®	NULL
g	NULL
i	NULL
:	NULL
v	NULL
y	NULL
vOI	NULL
EOE	NULL
A	NULL
g	NULL
p	NULL
oL	NULL
517	NULL
a	NULL
JJ	NULL
1872	NULL
VHO	NULL
LOT	NULL
W	NULL
B	NULL
L	NULL
#	NULL
0	NULL
f	NULL
POL	NULL
B	NULL
L	NULL
A	NULL
V	NULL
I	NULL
f	NULL
&	NULL
g	NULL
f	NULL
$	NULL
S41	NULL
1944	NULL
¥_Vv_S	NULL
F	NULL
L	NULL
L	NULL
_R	NULL
V	NULL
G	NULL
A	NULL
D	NULL
P	NULL
A	NULL
L	NULL
L	NULL
D	NULL
R	NULL
B	NULL
@	NULL
p	NULL
§	NULL
A	NULL
MOB	NULL
565	NULL
201	NULL
ULIAGAGAPlLl-RALLQSQAPAVSIg	NULL
T	NULL
2088	NULL
®	NULL
Q	NULL
L	NULL
pOBOM	NULL
P	NULL
D	NULL
r	NULL
E	NULL
G	NULL
L	NULL
Y	NULL
P	NULL
V	NULL
EOL	NULL
A	NULL
V	NULL
®	NULL
A	NULL
R	NULL
$	NULL
OP	NULL
§13	NULL
2160	NULL
E_G	NULL
L_D	NULL
L	NULL
L	NULL
v	NULL
p	NULL
s	NULL
g	NULL
a	NULL
go	NULL
v	NULL
A	NULL
TE	NULL
R	NULL
R	NULL
Y	NULL
A	NULL
637	NULL
LlLATIN	NULL
]	NULL
!	NULL

LGLV	NULL
‘	NULL
rlLV	NULL
‘	NULL
l'Rl-Rklggzi	NULL
a-	NULL
F	NULL
2304	NULL
A	NULL
G	NULL
M	NULL
T	NULL
POL	NULL
HOL	NULL
A	NULL
A	NULL
G	NULL
L	NULL
G	NULL
Y	NULL
P	NULL
T	NULL
L	NULL
f	NULL
R	NULL
685	NULL
2376	NULL
L	NULL
E	NULL
A	NULL
G	NULL
A	NULL
p	NULL
If	NULL
H	NULL
A	NULL
E	NULL
W	NULL
E	NULL
£	NULL
POL	NULL
CoP	NULL
L	NULL
B	NULL
§	NULL
bor	NULL
Tos	NULL
T'DSDSDSIGIIIDT	NULL
!	NULL

§SIIQITP2	NULL
``	NULL
'	NULL
;	NULL
;	NULL
TCT	NULL
recrec	NULL
2320	NULL
TlVlTl-LILIAAQH	NULL
'	NULL
I'NIPPTS	NULL
'	NULL
I	NULL
s	NULL
Z	NULL
2592	NULL
®	NULL
Q	NULL
L	NULL
781	NULL
DGPIAQGS'AILAIILGLRSLVﬁzggg	NULL
7	NULL
TYIQTTSPSGSLl-ISYILAGGol-Azigg	NULL
GLLIALSDNGLIIGVILLRGPlTl2=gg	NULL
LTPPSPAGPGLSLGDTll-Q-l-	NULL
E	NULL
2881	NULL
I	NULL
’	NULL
ll-ISTTIVIIDSAIGSQSVIQKADTg	NULL
IILGPPPIPPGGLCHGIPQPQV.2333	NULL
T	NULL
Al	NULL
TATTTA	NULL
3024	NULL
TTccca	NULL
2096	NULL
3113	NULL
peats	NULL
(	NULL
1	NULL
,	NULL
6	NULL
,	NULL
24	NULL
,	NULL
30	NULL
)	NULL
.	NULL

These	NULL
two	NULL
domains	NULL
are	NULL
separated	NULL
by	NULL
a	NULL
glycine-rich	NULL
spacer	NULL
region	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
overall	NULL
structure	NULL
of	NULL
p97	NULL
is	NULL
very	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
precursor	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
(	NULL
p105	NULL
)	NULL
(	NULL
6	NULL
,	NULL
13	NULL
,	NULL
24	NULL
,	NULL
31	NULL
)	NULL
.	NULL

p105	NULL
and	NULL
p97	NULL
differ	NULL
most	NULL
significantly	NULL
from	NULL
the	NULL
other	NULL
Rel-related	NULL
proteins	NULL
(	NULL
c-Rel	NULL
,	NULL
p65	NULL
,	NULL
RelB	NULL
[	NULL
39	NULL
]	NULL
,	NULL
and	NULL
Dorsal	NULL
)	NULL
in	NULL
that	NULL
they	NULL
contain	NULL
cell	NULL
cycle	NULL
repeats	NULL
.	NULL

In	NULL
vivo	NULL
processing	NULL
is	NULL
thought	NULL
to	NULL
remove	NULL
the	NULL
repeat	NULL
domain	NULL
from	NULL
p105	NULL
,	NULL
liberating	NULL
a	NULL
DNA-binding	NULL
p50	NULL
polypeptide	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
overall	NULL
identity	NULL
between	NULL
p105	NULL
and	NULL
p97	NULL
is	NULL
44	NULL
%	NULL
,	NULL
and	NULL
the	NULL
identity	NULL
in	NULL
the	NULL
amino-terminal	NULL
Rel-related	NULL
domain	NULL
is	NULL
61.5	NULL
%	NULL
.	NULL

The	NULL
comparison	NULL
of	NULL
the	NULL
amino-terminal	NULL
domain	NULL
of	NULL
p97	NULL
(	NULL
pS50B	NULL
)	NULL
with	NULL
the	NULL
various	NULL
Rel-related	NULL
proteins	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
.	NULL

Both	NULL
p50	NULL
and	NULL
pS50B	NULL
contain	NULL
a	NULL
short	NULL
stretch	NULL
of	NULL
amino	NULL
acids	NULL
in	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bro..	NULL
B	NULL
psos	NULL
PYLVIVEQPEQRGrRF	NULL
YPTVKICHYEG	NULL
50	NULL
p50	NULL
PYLOI	NULL
LEQPKORGFRFRYVCEGP	NULL
SHEGGLPGASSENXNKKSYPQVEICHYVG	NULL
50	NULL
pes	NULL
PYVEI	NULL
IEQPKQRGMRFRYECEGRSAGSIPGERSTDTTETHPTIRINGY	NULL
TG	NULL
so	NULL
c-Rel	NULL
PYIEIIEQPRORCMRFRYECEGRSAGSIPGERSTDNNRTYPSIQIMNYYG	NULL
50	NULL
RelB	NULL
PYLVITEQPEQRGMRFRYECEGRSAGSILGESSTEASKTOPAIELRDCGG	NULL
50	NULL
Dorsal	NULL
PMIHOPMRYlCtGRSAGSXPGVIISTPIHR	NULL
’	NULL
I	NULL
’	NULL
YPTIIIVGYKG	NULL
50	NULL
a*	NULL
,	NULL
%	NULL
)	NULL
wee	NULL
|	NULL
tke	NULL
#	NULL
#	NULL
,	NULL
.	NULL

%	NULL
®	NULL
.	NULL

0.0.2	NULL
#	NULL
ull	NULL
ll	NULL
#	NULL
pS0B	NULL
PARIEVD	NULL
-	NULL
-	NULL
LVTHSDPPRAHAHSLVGKQCSELGICAVSVGP	NULL
-	NULL
KDMTAQFN	NULL
97	NULL
p50	NULL
PARVIVQ-	NULL
-	NULL
LVTNGKNIELHARSLVGKHCED-GICTVTAGP	NULL
-KDNVVGFA	NULL
96	NULL
péS	NULL
PGTVRIS	NULL
-	NULL
-	NULL
LVTRDPPHRPHPEELVGKDCRD-GFYEAELCPDRCI	NULL
~ESFQ	NULL
96	NULL
c-Rel	NULL
KGEVRIT	NULL
-	NULL
-	NULL
LVTENDPYKP	NULL
HP	NULL
HD	NULL
LVGKDCRN	NULL
-	NULL
GY	NULL
YEAEFGQERRP	NULL
-	NULL
LFFQ	NULL
96	NULL
RelB	NULL
LREVEVTACLVWEDWP	NULL
HRVHPHSLVGKDCTD	NULL
-	NULL
GVCRVRLRPHVSPRESFN	NULL
99	NULL
Dorsal	NULL
_	NULL
RAVVVVSC	NULL
--	NULL
VTKDTPY	NULL
KEGVCTLEINSET-MRAVFS	NULL
97	NULL
.	NULL

#	NULL
;	NULL
;	NULL
Lw	NULL
,	NULL
a	NULL
tit	NULL
20	NULL
%	NULL
0	NULL
#	NULL
pS0B	NULL
NLGVLHVTKENMMGTMIQKLORQRLRSRPQGL	NULL
--	NULL
-	NULL
--	NULL
-	NULL
~	NULL
--	NULL
-	NULL
-	NULL
TEAEQRE	NULL
|	NULL
136	NULL
d	NULL
NLGILHVTKKEKVFETLEARMTEACIRGYNPG	NULL
146	NULL
péS	NULL
NLGIQCVKKRDLEGATISQRIQTNNINPFQVP	NULL
-	NULL
126	NULL
c-Rel	NULL
NLGIRCVEKEEVKEAT	NULL
I	NULL
TRIKAGINPFNVP	NULL
-	NULL
126	NULL
RelB	NULL
NLGIQCVREKKEIEAATERKIQLGIDPYNAG-	NULL
129	NULL
Dorsal	NULL
uwxocvmxmumsmvoprxm-	NULL
127	NULL
wee	NULL
,	NULL
0	NULL
%	NULL
p50B	NULL
LEQEAKEL	NULL
--	NULL
--	NULL
--	NULL
-~	NULL
KKVMDLSIVRLRFSAFL-RASDGSFSLPLEPVIS	NULL
|	NULL
177	NULL
d	NULL
LGDREKELIRQAALOOTEEMDLSVVRLMFTAFL-PDSTGSFTRRLEPVVS	NULL
|	NULL
195	NULL
p6§	NULL
0	NULL
IEE	NULL
~-	NULL
-	NULL
QRGDYDLNAVRLCFQVTV-RDPSGR-PLRLPPVLP	NULL
-	NULL
162	NULL
@	NULL
-ReA	NULL
0	NULL
EKQLNDIEDCDLNVVRLCFQVFL-PDEHGNLTTALPPVVS	NULL
-	NULL
165	NULL
ReLB	NULL
|	NULL
SLENHQEVDMNVVRICFQASY-RDQQCHLE-RMDPILS	NULL
|	NULL
165	NULL
Dorsal	NULL
|	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
FSHRFOPSSIDLNSVRLCEQVEMESEQKGRFTSPLPPVVS	NULL
|	NULL
167	NULL
#	NULL
#	NULL
#	NULL
U	NULL
#	NULL
#	NULL
pS0B	NULL
QPIHDSESPGASNLETI	NULL
SRMDKTAGSVRGGDEVYLLCDKVOKDDIEVRFYE	NULL
|	NULL
227	NULL
p50	NULL
DAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDEVOEDDIQIRFYE	NULL
|	NULL
245	NULL
péS	NULL
HPIFDNRAPNTAELKICRVNRNSGSCLGGDEIFLLCDEVQKEDIEVYFTG	NULL
-	NULL
212	NULL
c-Rel	NULL
WP	NULL
I	NULL
YDNRAPNTAELRICRVNKNCGSVRGGDEIFLLCDEVORDDIEVRFVL	NULL
_	NULL
215	NULL
RelB	NULL
EPVYDEKSTNTSELRICRINKESGPCTGGEELYLLCDEKVOQXEDISVVFST	NULL
|	NULL
215	NULL
Dorsal	NULL
-	NULL
EPIFDEKAM-	NULL
-sm.v1cnx.cscsawrcmx	NULL
ILLCEKVAKEDISVRFFE	NULL
|	NULL
215	NULL
22	NULL
%	NULL
0	NULL
%	NULL
®	NULL
.	NULL

%	NULL
tou	NULL
22	NULL
,	NULL
tect	NULL
ten	NULL
|	NULL
t	NULL
)	NULL
wn	NULL
|	NULL
ow	NULL
pSOB	NULL
DDENG-	NULL
-WOAFGDFSPTDVHKQYAIVFRTPPYHEMEKIERPVTVFLQLEREK	NULL
|	NULL
275	NULL
p50	NULL
EEENGGVWEGFGDF	NULL
SP	NULL
TDVHRQFAIVFKTPEYKD	NULL
INI	NULL
TRPASVFVOLRRE	NULL
295	NULL
péS	NULL
~WEARGSF	NULL
SQADVHRQVA	NULL
IVF	NULL
RTPPYADP	NULL
S	NULL
LQAPVRVSMQLRRP	NULL
257	NULL
c-Rel	NULL
-WEAKGIFSQADVHRQVAIVFKTPPYCKA	NULL
~I	NULL
TEPVTVKMQLRRP	NULL
|	NULL
259	NULL
RelB	NULL
AS	NULL
--	NULL
-~-~	NULL
WEGRADFSQADVHRQIAIVFKTPPYEDLEISEPVTVNVFLQRL	NULL
|	NULL
260	NULL
Dorsal	NULL
uncommmrqnmmmunmnnrmxnumxomr	NULL
265	NULL
wool	NULL
,	NULL
terets	NULL
we	NULL
t	NULL
wn	NULL
ow	NULL
#	NULL
pSOB	NULL
RGGDVSDSKQFTYYPLVEDKEEVORKRRK	NULL
|	NULL
304	NULL
p50	NULL
SDLETSEPKPFLYYPEIKDKEEVORKRQK	NULL
.	NULL

324	NULL
p6S	NULL
SDRELSEPMEFOYLPDTDDRERIEEKRKR	NULL
286	NULL
c-Rel	NULL
|	NULL
288	NULL
RelB	NULL
TDGVCSEPLPFTYLPRDHDSYGVDKKRKR	NULL
289	NULL
Dorsal	NULL
SDGVTSMFIWMSDPMMRRQK	NULL
294	NULL
-	NULL
*..	NULL
#	NULL
#	NULL
%	NULL
#	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nucleotide	NULL
sequence	NULL
and	NULL
predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
p50B/p97	NULL
(	NULL
clone	NULL
189	NULL
)	NULL
.	NULL

The	NULL
Rel-related	NULL
domain	NULL
,	NULL
the	NULL
glycine-rich	NULL
stretch	NULL
,	NULL
and	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
ankyrin	NULL
)	NULL
repeat	NULL
motifs	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
individual	NULL
repeats	NULL
are	NULL
underlined	NULL
.	NULL

Numbering	NULL
of	NULL
nucleotides	NULL
and	NULL
amino	NULL
acids	NULL
is	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
.	NULL

The	NULL
predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
differs	NULL
from	NULL
that	NULL
in	NULL
reference	NULL
40	NULL
at	NULL
the	NULL
following	NULL
positions	NULL
of	NULL
our	NULL
sequence	NULL
:	NULL
144	NULL
(	NULL
E	NULL
,	NULL
K	NULL
)	NULL
,	NULL
213	NULL
(	NULL
I	NULL
,	NULL
T	NULL
)	NULL
,	NULL
396	NULL
(	NULL
G	NULL
,	NULL
R	NULL
)	NULL
,	NULL
433	NULL
and	NULL
434	NULL
(	NULL
DA	NULL
,	NULL
EP	NULL
)	NULL
,	NULL
455	NULL
to	NULL
470	NULL
(	NULL
QRSARALLDYGVTAD	NULL
,	NULL
HAAPSPTRLLRHRG	NULL
)	NULL
,	NULL
741	NULL
(	NULL
K	NULL
,	NULL
L	NULL
)	NULL
,	NULL
859	NULL
and	NULL
860	NULL
(	NULL
TT	NULL
,	NULL
T	NULL
)	NULL
,	NULL
891	NULL
(	NULL
C	NULL
,	NULL
$	NULL
)	NULL
,	NULL
and	NULL
900	NULL
(	NULL
H	NULL
,	NULL
T	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
predicted	NULL
sequence	NULL
terminates	NULL
after	NULL
amino	NULL
acid	NULL
900	NULL
,	NULL
whereas	NULL
theirs	NULL
continues	NULL
for	NULL
35	NULL
more	NULL
amino	NULL
acids	NULL
.	NULL

A	NULL
distinct	NULL
cDNA	NULL
clone	NULL
of	NULL
ours	NULL
codes	NULL
for	NULL
a	NULL
K	NULL
instead	NULL
of	NULL
an	NULL
E	NULL
at	NULL
position	NULL
144	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Amino	NULL
acid	NULL
comparison	NULL
of	NULL
the	NULL
amino-terminal	NULL
domains	NULL
of	NULL
p50B	NULL
,	NULL
pS0/xBF-1/243	NULL
(	NULL
6	NULL
)	NULL
,	NULL
human	NULL
p65	NULL
(	NULL
38	NULL
)	NULL
,	NULL
mouse	NULL
RelB	NULL
(	NULL
39	NULL
)	NULL
,	NULL
human	NULL
c-Rel	NULL
(	NULL
7	NULL
)	NULL
,	NULL
and	NULL
Dorsal	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Stars	NULL
indicate	NULL
amino	NULL
acid	NULL
identity	NULL
among	NULL
the	NULL
six	NULL
proteins	NULL
,	NULL
and	NULL
dots	NULL
indicate	NULL
similar	NULL
amino	NULL
acids	NULL
.	NULL

Identity	NULL
between	NULL
the	NULL
amino-terminal	NULL
domain	NULL
of	NULL
p50B	NULL
and	NULL
these	NULL
related	NULL
proteins	NULL
is	NULL
61.5	NULL
%	NULL
with	NULL
p50	NULL
,	NULL
44.1	NULL
%	NULL
with	NULL
p65	NULL
,	NULL
41.5	NULL
%	NULL
with	NULL
RelB	NULL
,	NULL
45.1	NULL
%	NULL
with	NULL
c-Rel	NULL
,	NULL
44.8	NULL
%	NULL
with	NULL
v-Rel	NULL
,	NULL
and	NULL
40.8	NULL
%	NULL
with	NULL
Dorsal	NULL
.	NULL

the	NULL
middle	NULL
of	NULL
the	NULL
Rel	NULL
homology	NULL
region	NULL
not	NULL
found	NULL
in	NULL
c-Rel	NULL
,	NULL
p65	NULL
,	NULL
or	NULL
Dorsal	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
but	NULL
these	NULL
additional	NULL
amino	NULL
acids	NULL
are	NULL
not	NULL
well	NULL
conserved	NULL
between	NULL
the	NULL
two	NULL
proteins	NULL
.	NULL

A	NULL
further	NULL
distinguishing	NULL
feature	NULL
of	NULL
pS5OB	NULL
is	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
putative	NULL
phosphorylation	NULL
site	NULL
for	NULL
protein	NULL
kinase	NULL
A	NULL
(	NULL
RRXS	NULL
)	NULL
found	NULL
in	NULL
all	NULL
other	NULL
Rel-related	NULL
proteins	NULL
;	NULL
the	NULL
equivalent	NULL
amino	NULL
acids	NULL
in	NULL
p50B	NULL
are	NULL
KRKR	NULL
(	NULL
starting	NULL
with	NULL
amino	NULL
acid	NULL
number	NULL
310	NULL
)	NULL
.	NULL

A	NULL
nearby	NULL
putative	NULL
nuclear	NULL
localization	NULL
signal	NULL
(	NULL
15	NULL
,	NULL
17	NULL
)	NULL
is	NULL
present	NULL
in	NULL
all	NULL
proteins	NULL
of	NULL
this	NULL
family	NULL
,	NULL
including	NULL
p50B	NULL
(	NULL
amino	NULL
acids	NULL
337	NULL
to	NULL
341	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

This	NULL
signal	NULL
is	NULL
located	NULL
at	NULL
the	NULL
end	NULL
of	NULL
the	NULL
Rel	NULL
homology	NULL
region	NULL
.	NULL

Apart	NULL
from	NULL
the	NULL
Rel	NULL
domain	NULL
and	NULL
the	NULL
gly	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
P50B/p97	NULL
,	NULL
A	NULL
NEW	NULL
PROTEIN	NULL
RELATED	NULL
TO	NULL
r50/p105-NF-	NULL
«	NULL
B	NULL
689	NULL
-	NULL
X	NULL
A	NULL
B	NULL
g	NULL
&	NULL
LFF	NULL
SFS	NULL
LS	NULL
x	NULL
©	NULL
$	NULL
a	NULL
_é	NULL
‘	NULL
pSOB/p97	NULL
«	NULL
_C	NULL
Q	NULL
&	NULL
$	NULL
&	NULL
&	NULL
a	NULL
Ao	NULL
(	NULL
$	NULL
00	NULL
50°	NULL
$	NULL
20	NULL
Rel	NULL
homology	NULL
Gly	NULL
Repeats	NULL
[	NULL
ps-	NULL
A	NULL
[	NULL
|	NULL
Afl	NULL
Sma	NULL
Pst	NULL
Nde	NULL
Kpn	NULL
Xho	NULL
Sac	NULL
1	NULL
2	NULL
``	NULL
3°	NULL
4.9	NULL
``	NULL
6	NULL
1	NULL
m	NULL
\o	NULL
€	NULL
F	NULL
#	NULL
D	NULL
A	NULL
#	NULL
A	NULL
g	NULL
A	NULL
A	NULL
$	NULL
x	NULL
$	NULL
¢	NULL
£	NULL
SG	NULL
P8	NULL
&	NULL
;	NULL
&	NULL
C	NULL
€	NULL
&	NULL
C	NULL
#	NULL
£	NULL
a	NULL
Aa	NULL
ag	NULL
3	NULL
(	NULL
00Q3	NULL
‘	NULL
50Q7	NULL
A	NULL
&	NULL
A	NULL
5270750	NULL
of	NULL
§	NULL
¢	NULL
P	NULL
¢	NULL
¢	NULL
€	NULL
4	NULL
&	NULL
9	NULL
#	NULL
2	NULL
¢	NULL
$	NULL
ta	NULL
#	NULL
B	NULL
i	NULL
i	NULL
%	NULL
bild	NULL
w.	NULL
i	NULL
«	NULL
#	NULL
#	NULL
f	NULL
I	NULL
==	NULL
en	NULL
fu	NULL
«	NULL
b	NULL
«	NULL
f	NULL
a~=~~¥	NULL
&	NULL
%	NULL
;	NULL
b	NULL
€	NULL
$	NULL
3	NULL
3	NULL
4	NULL
5/6	NULL
12	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Restriction	NULL
enzyme	NULL
sites	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
to	NULL
produce	NULL
in	NULL
vitro-truncated	NULL
products	NULL
and	NULL
their	NULL
relative	NULL
positions	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
different	NULL
domains	NULL
of	NULL
the	NULL
p50B/p97	NULL
protein	NULL
.	NULL

These	NULL
sites	NULL
are	NULL
located	NULL
at	NULL
the	NULL
following	NULL
nucleotide	NULL
positions	NULL
:	NULL
AffIII	NULL
,	NULL
1197	NULL
;	NULL
Smal	NULL
,	NULL
1444	NULL
;	NULL
Pstl	NULL
,	NULL
1568	NULL
;	NULL
Xho	NULL
,	NULL
1575	NULL
;	NULL
Sacl	NULL
,	NULL
1578	NULL
;	NULL
Ndel	NULL
,	NULL
2030	NULL
;	NULL
and	NULL
Kpn1	NULL
,	NULL
2286	NULL
.	NULL

(	NULL
B	NULL
)	NULL
In	NULL
vitro-translated	NULL
pS0B	NULL
binds	NULL
DNA	NULL
.	NULL

The	NULL
Bluescript	NULL
construct	NULL
of	NULL
p97	NULL
cut	NULL
with	NULL
Pst	NULL
]	NULL
(	NULL
necleotide	NULL
1568	NULL
)	NULL
(	NULL
p50B	NULL
)	NULL
and	NULL
a	NULL
Pstl-linearized	NULL
version	NULL
of	NULL
the	NULL
TAGpS0B	NULL
construct	NULL
(	NULL
pMR-TAGpS0B	NULL
)	NULL
were	NULL
used	NULL
for	NULL
in	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
(	NULL
wheat	NULL
germ	NULL
extract	NULL
)	NULL
.	NULL

The	NULL
translated	NULL
product	NULL
was	NULL
incubated	NULL
with	NULL
a	NULL
labeled	NULL
PD-	NULL
«	NULL
B	NULL
and	NULL
run	NULL
on	NULL
an	NULL
EMSA	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
binding	NULL
of	NULL
p50B	NULL
;	NULL
2	NULL
,	NULL
competition	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
probe	NULL
;	NULL
3	NULL
,	NULL
competition	NULL
with	NULL
the	NULL
mutant	NULL
probe	NULL
;	NULL
4	NULL
,	NULL
binding	NULL
of	NULL
the	NULL
TAGpS0B	NULL
;	NULL
5	NULL
and	NULL
6	NULL
,	NULL
competition	NULL
of	NULL
the	NULL
TAGpS0B	NULL
binding	NULL
with	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
mutant	NULL
(	NULL
mt	NULL
)	NULL
unlabeled	NULL
probes	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
C	NULL
)	NULL
In	NULL
vitro	NULL
translations	NULL
of	NULL
truncated	NULL
p50B/p97	NULL
proteins	NULL
.	NULL

The	NULL
pMR-TAGp97	NULL
plasmid	NULL
was	NULL
linearized	NULL
at	NULL
different	NULL
restriction	NULL
sites	NULL
and	NULL
used	NULL
for	NULL
in	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
(	NULL
wheat	NULL
germ	NULL
extract	NULL
)	NULL
to	NULL
generate	NULL
truncated	NULL
proteins	NULL
of	NULL
progressively	NULL
decreasing	NULL
size	NULL
,	NULL
The	NULL
restriction	NULL
enzymes	NULL
used	NULL
were	NULL
BamHI	NULL
,	NULL
to	NULL
generate	NULL
a	NULL
full-length	NULL
TAGp97	NULL
protein	NULL
(	NULL
p97	NULL
FL	NULL
.	NULL

,	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
KpnI	NULL
(	NULL
p97	NULL
Kpn	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
Ndel	NULL
(	NULL
p97	NULL
Nde	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
PstI	NULL
(	NULL
p50B	NULL
[	NULL
p97	NULL
Pst	NULL
,	NULL
lane	NULL
4	NULL
]	NULL
)	NULL
,	NULL
Smal	NULL
(	NULL
pSOB	NULL
[	NULL
p97	NULL
Sma	NULL
,	NULL
lane	NULL
5	NULL
]	NULL
)	NULL
,	NULL
and	NULL
AffllI	NULL
(	NULL
p50B	NULL
Afl	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Molecular	NULL
mass	NULL
markers	NULL
(	NULL
Rainbow	NULL
markers	NULL
;	NULL
Amersham	NULL
(	NULL
200	NULL
,	NULL
97.4	NULL
,	NULL
69	NULL
,	NULL
and	NULL
46	NULL
kDa	NULL
)	NULL
are	NULL
shown	NULL
in	NULL
lane	NULL
0	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
major	NULL
product	NULL
,	NULL
each	NULL
lane	NULL
shows	NULL
several	NULL
smaller	NULL
species	NULL
,	NULL
which	NULL
probably	NULL
result	NULL
from	NULL
prematurely	NULL
terminated	NULL
translation	NULL
products	NULL
in	NULL
the	NULL
wheat	NULL
germ	NULL
system	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Binding	NULL
of	NULL
the	NULL
variously	NULL
truncated	NULL
proteins	NULL
to	NULL
the	NULL
PD-	NULL
«	NULL
kB	NULL
probe	NULL
.	NULL

The	NULL
in	NULL
vitro-translated	NULL
products	NULL
described	NULL
in	NULL
panel	NULL
C	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
PD-	NULL
«	NULL
B	NULL
probe	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
resulting	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
an	NULL
EMSA	NULL
.	NULL

cine-rich	NULL
region	NULL
,	NULL
the	NULL
homology	NULL
between	NULL
the	NULL
p105	NULL
and	NULL
p97	NULL
is	NULL
confined	NULL
almost	NULL
entirely	NULL
to	NULL
the	NULL
repeats	NULL
(	NULL
analysis	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
amino-terminal	NULL
half	NULL
of	NULL
p97	NULL
(	NULL
pS50B	NULL
)	NULL
binds	NULL
«	NULL
B	NULL
DNA	NULL
sites	NULL
.	NULL

Given	NULL
the	NULL
high	NULL
degree	NULL
of	NULL
similarity	NULL
to	NULL
p50/p105-NF-	NULL
«	NULL
B	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
binding	NULL
to	NULL
«	NULL
B	NULL
sites	NULL
by	NULL
a	NULL
p97	NULL
truncated	NULL
polypeptide	NULL
analogous	NULL
to	NULL
p50	NULL
truncations	NULL
(	NULL
pSOB	NULL
)	NULL
.	NULL

Wheat	NULL
germ	NULL
extracts	NULL
programmed	NULL
with	NULL
in	NULL
vitro-transcribed	NULL
RNA	NULL
of	NULL
p97	NULL
truncated	NULL
near	NULL
the	NULL
glycine-rich	NULL
domain	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
shows	NULL
a	NULL
map	NULL
of	NULL
p50B/p97	NULL
and	NULL
various	NULL
truncations	NULL
including	NULL
the	NULL
PstI	NULL
site	NULL
used	NULL
here	NULL
)	NULL
yielded	NULL
a	NULL
product	NULL
(	NULL
pSOB	NULL
)	NULL
which	NULL
could	NULL
bind	NULL
a	NULL
palindromic	NULL
kB	NULL
oligonucleotide	NULL
(	NULL
PD-	NULL
«	NULL
B	NULL
)	NULL
in	NULL
an	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
was	NULL
specific	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
competition	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
wild-type	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
oligonucleotide	NULL
for	NULL
the	NULL
kB	NULL
site	NULL
;	NULL
only	NULL
the	NULL
wild-type	NULL
«	NULL
kB	NULL
site	NULL
competed	NULL
.	NULL

Since	NULL
the	NULL
specific	NULL
band	NULL
in	NULL
this	NULL
experiment	NULL
migrated	NULL
at	NULL
the	NULL
position	NULL
of	NULL
a	NULL
weaker	NULL
nonspecific	NULL
band	NULL
,	NULL
competition	NULL
appeared	NULL
not	NULL
to	NULL
be	NULL
complete	NULL
.	NULL

Complete	NULL
competition	NULL
was	NULL
evident	NULL
,	NULL
however	NULL
,	NULL
when	NULL
the	NULL
same	NULL
experiment	NULL
was	NULL
repeated	NULL
with	NULL
a	NULL
slightly	NULL
larger	NULL
p50B	NULL
protein	NULL
,	NULL
creating	NULL
a	NULL
band	NULL
shift	NULL
migrating	NULL
more	NULL
slowly	NULL
than	NULL
the	NULL
nonspecific	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
.	NULL

In	NULL
this	NULL
case	NULL
a	NULL
short	NULL
TAG	NULL
epitope-encoding	NULL
sequence	NULL
was	NULL
fused	NULL
in	NULL
frame	NULL
to	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
p50B	NULL
,	NULL
yielding	NULL
a	NULL
slightly	NULL
bigger	NULL
product	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Meth-ods	NULL
)	NULL
;	NULL
this	NULL
TAG	NULL
construct	NULL
was	NULL
consistently	NULL
more	NULL
efficiently	NULL
translated	NULL
in	NULL
vitro	NULL
,	NULL
probably	NULL
owing	NULL
to	NULL
a	NULL
different	NULL
leader	NULL
sequence	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
stronger	NULL
band	NULL
shift	NULL
(	NULL
see	NULL
also	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

690	NULL
BOURS	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bro..	NULL
\	NULL
B	NULL
&	NULL
~	NULL
a	NULL
6	NULL
sox	NULL
«	NULL
£	NULL
®	NULL
FQ	NULL
)	NULL
62	NULL
?	NULL

de	NULL
C	NULL
£	NULL
¢	NULL
o	NULL
$	NULL
£8	NULL
'	NULL
``	NULL
G	NULL
<	NULL
.	NULL

AsPO	NULL
P	NULL
&	NULL
C	NULL
€	NULL
£	NULL
Csaw	NULL
.	NULL

&	NULL
¥	NULL
a	NULL
S	NULL
C	NULL
$	NULL
Jz	NULL
3	NULL
32°	NULL
$	NULL
'	NULL
€	NULL
Lo	NULL
.	NULL

,	NULL
o	NULL
N	NULL
&	NULL
58	NULL
af	NULL
8	NULL
o	NULL
0°	NULL
9	NULL
C	NULL
)	NULL
«	NULL
Yy	NULL
€	NULL
.	NULL

Ce	NULL
©	NULL
at	NULL
NZQ	NULL
$	NULL
2	NULL
22	NULL
2	NULL
s	NULL
£	NULL
.	NULL

[	NULL
*	NULL
x	NULL
``	NULL
y*	NULL
.	NULL
``	NULL

p	NULL
)	NULL
.2,0	NULL
,	NULL
.0.0	NULL
,	NULL
.0,0,0	NULL
,	NULL
$	NULL
&	NULL
©	NULL
a	NULL
25222828222	NULL
9	NULL
S9	NULL
,	NULL
``	NULL
5	NULL
2282	NULL
2	NULL
N	NULL
&	NULL
a	NULL
,	NULL
P	NULL
RCO	NULL
Cec	NULL
Acc	NULL
o	NULL
R	NULL
COQ	NULL
CA	NULL
@	NULL
R	NULL
cA	NULL
©	NULL
``	NULL
o*	NULL
$	NULL
Asas	NULL
(	NULL
g	NULL
)	NULL
AT	NULL
AX	NULL
fas	NULL
«	NULL
YUQY	NULL
rar	NULL
Q6	NULL
)	NULL
ar	NULL
K	NULL
‘	NULL
ré	NULL
’	NULL
?	NULL

ar	NULL
ay	NULL
Q6	NULL
)	NULL
Rs	NULL
ar	NULL
rar	NULL
AY	NULL
636527630	NULL
?	NULL

’	NULL
6°	NULL
(	NULL
9	NULL
&	NULL
6	NULL
?	NULL

°	NULL
g	NULL
ad	NULL
d	NULL
j	NULL
is	NULL
ﬂ	NULL
(	NULL
``	NULL
I_	NULL
i	NULL
#	NULL
e¥	NULL
®	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
+	NULL
sf	NULL
$	NULL
*	NULL
y	NULL
4	NULL
26	NULL
L	NULL
cerca	NULL
)	NULL
,	NULL
yy	NULL
PD-kB	NULL
HIV-KB	NULL
D-kB	NULL
HIV-KB	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

(	NULL
A	NULL
)	NULL
pS0B	NULL
and	NULL
RelB	NULL
form	NULL
a	NULL
heterodimer	NULL
.	NULL

p50B	NULL
,	NULL
TAGp50B	NULL
(	NULL
Pst	NULL
truncations	NULL
[	NULL
see	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

3B	NULL
]	NULL
)	NULL
,	NULL
and	NULL
RelB	NULL
were	NULL
produced	NULL
by	NULL
in	NULL
vitro	NULL
translations	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
as	NULL
specified	NULL
.	NULL

The	NULL
products	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
palindromic	NULL
probe	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
8	NULL
)	NULL
or	NULL
the	NULL
HIV	NULL
probe	NULL
(	NULL
lanes	NULL
9	NULL
to	NULL
12	NULL
)	NULL
and	NULL
run	NULL
on	NULL
an	NULL
EMSA	NULL
with	NULL
or	NULL
without	NULL
TAG	NULL
antibodies	NULL
(	NULL
TAG-AB	NULL
)	NULL
or	NULL
RelB	NULL
antibodies	NULL
(	NULL
Rel-AB	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

Lanes	NULL
11	NULL
and	NULL
12	NULL
show	NULL
competition	NULL
with	NULL
unlabeled	NULL
wild-type	NULL
(	NULL
wt	NULL
,	NULL
lane	NULL
11	NULL
)	NULL
and	NULL
mutant	NULL
(	NULL
mt	NULL
,	NULL
lane	NULL
12	NULL
)	NULL
probes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
p50B	NULL
and	NULL
p50	NULL
form	NULL
a	NULL
heterodimer	NULL
.	NULL

p50B	NULL
and	NULL
TAGpS50B	NULL
were	NULL
produced	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legends	NULL
to	NULL
Fig	NULL
.	NULL

3B	NULL
and	NULL
4A	NULL
.	NULL

pSO	NULL
and	NULL
TAGp50	NULL
were	NULL
generated	NULL
from	NULL
Bluescript	NULL
and	NULL
pMR-TAGp50	NULL
vectors	NULL
,	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
palindromic	NULL
probe	NULL
(	NULL
PD-kB	NULL
)	NULL
was	NULL
used	NULL
in	NULL
these	NULL
EMSAs	NULL
.	NULL

Competitions	NULL
with	NULL
unlabeled	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
mutant	NULL
(	NULL
mt	NULL
)	NULL
PD-	NULL
«	NULL
B	NULL
probes	NULL
are	NULL
shown	NULL
in	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
C	NULL
)	NULL
p50B	NULL
and	NULL
p65	NULL
form	NULL
heterodimers	NULL
.	NULL

The	NULL
full-length	NULL
pMR-TAGp97	NULL
construct	NULL
truncated	NULL
at	NULL
the	NULL
Smal	NULL
site	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
)	NULL
(	NULL
pSOB	NULL
)	NULL
and	NULL
p65	NULL
were	NULL
translated	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
(	NULL
wheat	NULL
germ	NULL
)	NULL
.	NULL

In	NULL
vitro-translated	NULL
products	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
palindromic	NULL
probe	NULL
(	NULL
PD-	NULL
«	NULL
B	NULL
)	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
or	NULL
with	NULL
the	NULL
HIV	NULL
probe	NULL
(	NULL
HIV-	NULL
«	NULL
B	NULL
)	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
.	NULL

The	NULL
TAG	NULL
construct	NULL
was	NULL
generated	NULL
to	NULL
permit	NULL
unique	NULL
identification	NULL
of	NULL
the	NULL
encoded	NULL
protein	NULL
product	NULL
by	NULL
monoclonal	NULL
antibodies	NULL
directed	NULL
at	NULL
the	NULL
TAG	NULL
epitope	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

We	NULL
did	NULL
not	NULL
observe	NULL
binding	NULL
by	NULL
p50B	NULL
to	NULL
the	NULL
HIV-kB	NULL
sites	NULL
(	NULL
see	NULL
below	NULL
)	NULL
,	NULL
suggesting	NULL
at	NULL
least	NULL
a	NULL
much	NULL
reduced	NULL
affinity	NULL
for	NULL
this	NULL
site	NULL
.	NULL

We	NULL
also	NULL
tested	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
in	NULL
vitro-translated	NULL
p97	NULL
truncated	NULL
at	NULL
a	NULL
number	NULL
of	NULL
different	NULL
sites	NULL
to	NULL
yield	NULL
sequentially	NULL
longer	NULL
products	NULL
.	NULL

Previous	NULL
work	NULL
with	NULL
the	NULL
precursor	NULL
p105	NULL
protein	NULL
had	NULL
shown	NULL
that	NULL
the	NULL
carboxy-terminal	NULL
domain	NULL
inhibited	NULL
DNA	NULL
binding	NULL
by	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
(	NULL
6	NULL
,	NULL
13	NULL
,	NULL
24	NULL
,	NULL
31	NULL
)	NULL
.	NULL

The	NULL
carboxy-terminal	NULL
domain	NULL
of	NULL
p97	NULL
appears	NULL
to	NULL
possess	NULL
a	NULL
similar	NULL
function	NULL
.	NULL

Protein	NULL
translations	NULL
of	NULL
full-length	NULL
p97	NULL
RNA	NULL
or	NULL
of	NULL
truncations	NULL
resulting	NULL
in	NULL
RNAs	NULL
which	NULL
preserve	NULL
several	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
repeats	NULL
were	NULL
less	NULL
able	NULL
to	NULL
bind	NULL
the	NULL
palindromic	NULL
«	NULL
kB	NULL
(	NULL
PD-	NULL
«	NULL
B	NULL
)	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
p97	NULL
FL	NULL
,	NULL
p97	NULL
Kpn	NULL
,	NULL
p97	NULL
Nde	NULL
[	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
,	NULL
respectively	NULL
)	NULL
)	NULL
than	NULL
were	NULL
the	NULL
translations	NULL
of	NULL
truncations	NULL
which	NULL
removed	NULL
these	NULL
repeats	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
p50B	NULL
[	NULL
Pst	NULL
truncation	NULL
]	NULL
,	NULL
p50B	NULL
[	NULL
Sma	NULL
truncation	NULL
]	NULL
[	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
,	NULL
respectively	NULL
]	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
shows	NULL
corresponding	NULL
protein	NULL
translations	NULL
,	NULL
and	NULL
Fig	NULL
.	NULL

3A	NULL
gives	NULL
the	NULL
map	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
the	NULL
truncation	NULL
removed	NULL
part	NULL
of	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
,	NULL
no	NULL
binding	NULL
was	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
p50B	NULL
Afl	NULL
[	NULL
lane	NULL
6	NULL
]	NULL
)	NULL
.	NULL

The	NULL
small	NULL
but	NULL
detectable	NULL
amount	NULL
of	NULL
binding	NULL
observed	NULL
for	NULL
translations	NULL
of	NULL
the	NULL
longer	NULL
RNAs	NULL
,	NULL
and	NULL
especially	NULL
of	NULL
the	NULL
full-length	NULL
RNA	NULL
,	NULL
was	NULL
presumed	NULL
to	NULL
be	NULL
the	NULL
result	NULL
of	NULL
prematurely	NULL
terminated	NULL
protein	NULL
made	NULL
in	NULL
the	NULL
wheat	NULL
germ	NULL
system	NULL
.	NULL

Judging	NULL
from	NULL
its	NULL
size	NULL
,	NULL
a	NULL
prominent	NULL
peptide	NULL
species	NULL
appeared	NULL
to	NULL
be	NULL
terminated	NULL
around	NULL
the	NULL
glycine-rich	NULL
region	NULL
.	NULL

This	NULL
species	NULL
was	NULL
seen	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
larger	NULL
full-length	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
p97	NULL
FL	NULL
,	NULL
p97	NULL
Kpn	NULL
,	NULL
and	NULL
p97	NULL
Nde	NULL
[	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
,	NULL
respectively	NULL
]	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
band	NULL
shifts	NULL
seen	NULL
with	NULL
the	NULL
full-length	NULL
protein	NULL
translations	NULL
migrated	NULL
with	NULL
a	NULL
mobility	NULL
approximately	NULL
equal	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
the	NULL
PstI	NULL
truncation	NULL
(	NULL
p50B	NULL
)	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
prematurely	NULL
synthesized	NULL
products	NULL
were	NULL
responsible	NULL
;	NULL
if	NULL
the	NULL
full-length	NULL
protein	NULL
had	NULL
participated	NULL
in	NULL
the	NULL
binding	NULL
,	NULL
a	NULL
band	NULL
shift	NULL
of	NULL
much	NULL
slower	NULL
mobility	NULL
would	NULL
be	NULL
expected	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
it	NULL
is	NULL
relevant	NULL
to	NULL
note	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
shifts	NULL
generated	NULL
by	NULL
the	NULL
closely	NULL
spaced	NULL
PstI	NULL
and	NULL
Smal	NULL
truncations	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
p50B	NULL
Pst	NULL
and	NULL
p50B	NULL
Sma	NULL
[	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
,	NULL
respectively	NULL
)	NULL
)	NULL
.	NULL

p50B	NULL
forms	NULL
heteromeric	NULL
complexes	NULL
with	NULL
other	NULL
Rel-related	NULL
proteins	NULL
.	NULL

In	NULL
light	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
p50B	NULL
to	NULL
kB	NULL
sites	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
such	NULL
a	NULL
truncated	NULL
protein	NULL
could	NULL
form	NULL
<	NULL
B-binding	NULL
heteromeric	NULL
complexes	NULL
with	NULL
RelB	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
p65	NULL
.	NULL

RelB	NULL
is	NULL
a	NULL
novel	NULL
Rel-related	NULL
murine	NULL
protein	NULL
which	NULL
is	NULL
most	NULL
homologous	NULL
with	NULL
c-Rel	NULL
and	NULL
p65	NULL
and	NULL
has	NULL
no	NULL
cell	NULL
cycle	NULL
repeats	NULL
(	NULL
39	NULL
)	NULL
.	NULL

RelB	NULL
did	NULL
not	NULL
generate	NULL
a	NULL
specific	NULL
band	NULL
shift	NULL
with	NULL
various	NULL
kB	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
(	NULL
39	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
RelB	NULL
was	NULL
cotranslated	NULL
with	NULL
the	NULL
TAG-bearing	NULL
p50B	NULL
(	NULL
TAGpS50B	NULL
+	NULL
RelB	NULL
[	NULL
lane	NULL
6	NULL
]	NULL
)	NULL
,	NULL
a	NULL
clear	NULL
band	NULL
shift	NULL
appeared	NULL
which	NULL
migrated	NULL
more	NULL
slowly	NULL
than	NULL
the	NULL
one	NULL
created	NULL
by	NULL
TAGpS50B	NULL
alone	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

This	NULL
would	NULL
be	NULL
expected	NULL
if	NULL
TAGpS50B	NULL
(	NULL
439	NULL
+	NULL
32	NULL
amino	NULL
acids	NULL
from	NULL
the	NULL
TAG	NULL
)	NULL
and	NULL
the	NULL
somewhat	NULL
larger	NULL
RelB	NULL
protein	NULL
(	NULL
558	NULL
amino	NULL
acids	NULL
)	NULL
formed	NULL
a	NULL
heterodimer	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
heterodimer	NULL
formed	NULL
between	NULL
p50	NULL
and	NULL
p65	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Heteromeric	NULL
complexes	NULL
between	NULL
p50B/p97	NULL
and	NULL
RelB	NULL
could	NULL
be	NULL
shown	NULL
independently	NULL
by	NULL
their	NULL
coimmunoprecipitation	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
The	NULL
p50B	NULL
construct	NULL
without	NULL
the	NULL
amino-terminal	NULL
TAG	NULL
sequence	NULL
was	NULL
translated	NULL
more	NULL
weakly	NULL
here	NULL
,	NULL
and	NULL
the	NULL
slightly	NULL
faster-migrating	NULL
band	NULL
shift	NULL
created	NULL
by	NULL
its	NULL
protein	NULL
product	NULL
was	NULL
seen	NULL
clearly	NULL
only	NULL
with	NULL
longer	NULL
exposures	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
2	NULL
;	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
p50B	NULL
without	NULL
TAG	NULL
also	NULL
formed	NULL
a	NULL
complex	NULL
with	NULL
the	NULL
RelB	NULL
protein	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
which	NULL
migrated	NULL
slightly	NULL
faster	NULL
than	NULL
the	NULL
corresponding	NULL
one	NULL
carrying	NULL
the	NULL
TAG	NULL
leader	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Generally	NULL
we	NULL
noted	NULL
a	NULL
stronger	NULL
band	NULL
shift	NULL
with	NULL
the	NULL
heteromeric	NULL
complex	NULL
relative	NULL
to	NULL
the	NULL
homomeric	NULL
p50B	NULL
complex	NULL
.	NULL

Additional	NULL
experiments	NULL
demonstrated	NULL
directly	NULL
that	NULL
the	NULL
distinct	NULL
band	NULL
shift	NULL
seen	NULL
with	NULL
cotranslations	NULL
of	NULL
ReIB	NULL
and	NULL
p50B	NULL
did	NULL
contain	NULL
both	NULL
proteins	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
to	NULL
the	NULL
TAG	NULL
epitope	NULL
present	NULL
at	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
pS0B	NULL
supershifted	NULL
the	NULL
heteromeric	NULL
complex	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
as	NULL
did	NULL
polyclonal	NULL
antibodies	NULL
to	NULL
the	NULL
ReIB	NULL
protein	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
the	NULL
supershifting	NULL
was	NULL
nearly	NULL
complete	NULL
;	NULL
little	NULL
or	NULL
no	NULL
complex	NULL
remained	NULL
at	NULL
the	NULL
original	NULL
position	NULL
.	NULL

The	NULL
RelB	NULL
antibodies	NULL
did	NULL
not	NULL
cross-react	NULL
with	NULL
p50B	NULL
(	NULL
see	NULL
below	NULL
)	NULL
,	NULL
and	NULL
the	NULL
monoclonal	NULL
TAG	NULL
antibodies	NULL
did	NULL
not	NULL
react	NULL
with	NULL
RelB	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Further	NULL
evidence	NULL
for	NULL
a	NULL
complex	NULL
between	NULL
p50B	NULL
and	NULL
RelB	NULL
was	NULL
revealed	NULL
in	NULL
experiments	NULL
with	NULL
the	NULL
HIV-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
probe	NULL
:	NULL
TAGpS50B	NULL
alone	NULL
did	NULL
not	NULL
bind	NULL
this	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
nor	NULL
did	NULL
RelB	NULL
alone	NULL
(	NULL
39	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
but	NULL
both	NULL
together	NULL
created	NULL
a	NULL
strong	NULL
band	NULL
shift	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
which	NULL
was	NULL
specific	NULL
for	NULL
the	NULL
«	NULL
B	NULL
site	NULL
as	NULL
shown	NULL
by	NULL
competition	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
and	NULL
mutant	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
.	NULL

The	NULL
better	NULL
binding	NULL
of	NULL
the	NULL
p50B	NULL
homomeric	NULL
complex	NULL
to	NULL
the	NULL
PD-	NULL
«	NULL
B	NULL
site	NULL
than	NULL
to	NULL
the	NULL
HIV-	NULL
«	NULL
B	NULL
site	NULL
mirrors	NULL
what	NULL
has	NULL
been	NULL
reported	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
p50	NULL
homodimer	NULL
(	NULL
46	NULL
)	NULL
.	NULL

The	NULL
p50	NULL
protein	NULL
and	NULL
the	NULL
p65	NULL
protein	NULL
apparently	NULL
contact	NULL
separate	NULL
halves	NULL
of	NULL
the	NULL
classical	NULL
KB	NULL
sites	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
PD-	NULL
«	NULL
B	NULL
(	NULL
PD-	NULL
«	NULL
kB	NULL
)	NULL
sequence	NULL
is	NULL
based	NULL
on	NULL
the	NULL
half	NULL
implicated	NULL
in	NULL
p50	NULL
binding	NULL
,	NULL
it	NULL
explains	NULL
the	NULL
preferential	NULL
binding	NULL
of	NULL
the	NULL
p50	NULL
homodimer	NULL
to	NULL
the	NULL
PD-	NULL
«	NULL
B	NULL
site	NULL
.	NULL

ReIB	NULL
was	NULL
able	NULL
to	NULL
form	NULL
DNA-binding	NULL
heteromeric	NULL
complexes	NULL
with	NULL
p50	NULL
as	NULL
well	NULL
(	NULL
39	NULL
)	NULL
.	NULL

In	NULL
experiments	NULL
analogous	NULL
to	NULL
those	NULL
above	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
p50	NULL
and	NULL
p50B	NULL
could	NULL
also	NULL
associate	NULL
.	NULL

Cotranslation	NULL
of	NULL
p50B	NULL
and	NULL
p50	NULL
led	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
distinct	NULL
heteromeric	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
p50B	NULL
+	NULL
p50	NULL
and	NULL
TAGp50B	NULL
+	NULL
p50	NULL
[	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
,	NULL
respectively	NULL
]	NULL
}	NULL
)	NULL
which	NULL
migrated	NULL
between	NULL
the	NULL
homomeric	NULL
p50	NULL
complex	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
the	NULL
corresponding	NULL
homomeric	NULL
p50B	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
p50B	NULL
or	NULL
TAGpS0B	NULL
[	NULL
lane	NULL
4	NULL
or	NULL
5	NULL
,	NULL
respectively	NULL
]	NULL
)	NULL
.	NULL

We	NULL
could	NULL
always	NULL
discern	NULL
the	NULL
formation	NULL
of	NULL
some	NULL
homomeric	NULL
p50	NULL
complexes	NULL
as	NULL
well	NULL
with	NULL
these	NULL
cotrans-lations	NULL
,	NULL
perhaps	NULL
reflecting	NULL
an	NULL
excess	NULL
of	NULL
this	NULL
protein	NULL
and/or	NULL
a	NULL
less	NULL
effective	NULL
association	NULL
with	NULL
p50B	NULL
.	NULL

We	NULL
noted	NULL
the	NULL
generally	NULL
stronger	NULL
binding	NULL
observed	NULL
with	NULL
p50	NULL
homomeric	NULL
complexes	NULL
than	NULL
with	NULL
p50B	NULL
homomeric	NULL
complexes	NULL
.	NULL

When	NULL
TAG	NULL
monoclonal	NULL
antibodies	NULL
were	NULL
added	NULL
to	NULL
the	NULL
cotranslation	NULL
of	NULL
p50	NULL
and	NULL
TAGpSQ0B	NULL
,	NULL
the	NULL
heteromeric	NULL
complex	NULL
was	NULL
supershifted	NULL
almost	NULL
completely	NULL
,	NULL
while	NULL
a	NULL
considerable	NULL
amount	NULL
of	NULL
p50	NULL
remained	NULL
behind	NULL
as	NULL
a	NULL
homomeric	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

We	NULL
also	NULL
were	NULL
able	NULL
to	NULL
supershift	NULL
a	NULL
heteromeric	NULL
complex	NULL
in	NULL
which	NULL
p50	NULL
rather	NULL
than	NULL
p50B	NULL
carried	NULL
the	NULL
TAG	NULL
epitope	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
heteromeric	NULL
complex	NULL
between	NULL
pS0OB	NULL
and	NULL
p50	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
was	NULL
sequence	NULL
specific	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
competition	NULL
with	NULL
wild-type	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
and	NULL
mutant	NULL
(	NULL
lane	NULL
12	NULL
)	NULL
PD-	NULL
«	NULL
kB	NULL
oligonucleotides	NULL
.	NULL

p50B	NULL
also	NULL
formed	NULL
heteromeric	NULL
complexes	NULL
with	NULL
p65	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Cotranslation	NULL
of	NULL
TAGpS0B	NULL
and	NULL
p65	NULL
formed	NULL
a	NULL
new	NULL
band	NULL
shift	NULL
not	NULL
seen	NULL
with	NULL
either	NULL
protein	NULL
alone	NULL
.	NULL

The	NULL
heteromeric	NULL
complex	NULL
could	NULL
be	NULL
supershifted	NULL
with	NULL
TAG	NULL
antibodies	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
bound	NULL
both	NULL
the	NULL
HIV-	NULL
«	NULL
B	NULL
site	NULL
and	NULL
the	NULL
PD-kB	NULL
site	NULL
.	NULL

The	NULL
relative	NULL
mobilities	NULL
of	NULL
the	NULL
homomeric	NULL
and	NULL
heteromeric	NULL
complexes	NULL
in	NULL
all	NULL
of	NULL
our	NULL
DNA-binding	NULL
experiments	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
conclusion	NULL
that	NULL
these	NULL
complexes	NULL
bind	NULL
as	NULL
P50B/p97	NULL
,	NULL
A	NULL
NEW	NULL
PROTEIN	NULL
RELATED	NULL
TO	NULL
r50/p105-NF-	NULL
«	NULL
B	NULL
691	NULL
dimers	NULL
,	NULL
although	NULL
we	NULL
have	NULL
not	NULL
directly	NULL
demonstrated	NULL
this	NULL
.	NULL

p50	NULL
and	NULL
p65	NULL
are	NULL
also	NULL
thought	NULL
to	NULL
bind	NULL
DNA	NULL
as	NULL
dimers	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
data	NULL
suggest	NULL
that	NULL
many	NULL
Rel-related	NULL
proteins	NULL
can	NULL
associate	NULL
with	NULL
each	NULL
other	NULL
and	NULL
bind	NULL
«	NULL
B	NULL
sites	NULL
,	NULL
although	NULL
they	NULL
may	NULL
do	NULL
so	NULL
differentially	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
stability	NULL
on	NULL
DNA	NULL
of	NULL
the	NULL
p50B	NULL
homomeric	NULL
complex	NULL
and	NULL
the	NULL
pS0B/ReIB	NULL
heteromeric	NULL
complex	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
6	NULL
)	NULL
,	NULL
the	NULL
complex	NULL
formed	NULL
by	NULL
p50B	NULL
with	NULL
the	NULL
radioactive	NULL
probe	NULL
decreased	NULL
with	NULL
time	NULL
during	NULL
a	NULL
challenge	NULL
with	NULL
a	NULL
500-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
,	NULL
but	NULL
was	NULL
still	NULL
detectable	NULL
after	NULL
4	NULL
h.	NULL
In	NULL
the	NULL
presence	NULL
of	NULL
5	NULL
to	NULL
10	NULL
mM	NULL
added	NULL
GTP	NULL
,	NULL
stability	NULL
was	NULL
increased	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
7	NULL
to	NULL
12	NULL
)	NULL
.	NULL

GTP	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
increase	NULL
the	NULL
binding	NULL
of	NULL
complexes	NULL
involving	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
4	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Given	NULL
our	NULL
experimental	NULL
design	NULL
,	NULL
the	NULL
data	NULL
suggest	NULL
that	NULL
,	NULL
at	NULL
least	NULL
for	NULL
p50B	NULL
,	NULL
it	NULL
is	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
homomeric	NULL
complex	NULL
with	NULL
kB	NULL
sites	NULL
which	NULL
is	NULL
enhanced	NULL
.	NULL

The	NULL
apparent	NULL
boost	NULL
in	NULL
the	NULL
strength	NULL
of	NULL
the	NULL
band	NULL
shift	NULL
with	NULL
increasing	NULL
time	NULL
of	NULL
competition	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GTP	NULL
probably	NULL
occurs	NULL
because	NULL
the	NULL
bands	NULL
are	NULL
less	NULL
diffuse	NULL
than	NULL
those	NULL
seen	NULL
with	NULL
the	NULL
longer	NULL
runs	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
the	NULL
complexes	NULL
are	NULL
slightly	NULL
unstable	NULL
in	NULL
gels	NULL
during	NULL
longer	NULL
runs	NULL
.	NULL

A	NULL
test	NULL
of	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
p50B/ReIB	NULL
heteromeric	NULL
complex	NULL
with	NULL
the	NULL
PD-	NULL
«	NULL
kB	NULL
probe	NULL
in	NULL
vitro	NULL
revealed	NULL
a	NULL
less	NULL
stable	NULL
complex	NULL
relative	NULL
to	NULL
the	NULL
homomeric	NULL
p50B	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
6	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
GTP	NULL
significantly	NULL
increased	NULL
the	NULL
amount	NULL
of	NULL
initial	NULL
binding	NULL
detected	NULL
prior	NULL
to	NULL
competition	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

The	NULL
stability	NULL
of	NULL
the	NULL
heteromeric	NULL
complex	NULL
increased	NULL
as	NULL
well	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
7	NULL
to	NULL
13	NULL
)	NULL
,	NULL
although	NULL
it	NULL
was	NULL
less	NULL
stable	NULL
than	NULL
the	NULL
homomeric	NULL
complex	NULL
with	NULL
GTP	NULL
.	NULL

A	NULL
qualitatively	NULL
similar	NULL
result	NULL
was	NULL
obtained	NULL
when	NULL
the	NULL
experiment	NULL
was	NULL
repeated	NULL
with	NULL
the	NULL
HIV-	NULL
«	NULL
kB	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
p50B/p65	NULL
heteromeric	NULL
complex	NULL
was	NULL
also	NULL
enhanced	NULL
in	NULL
its	NULL
initial	NULL
binding	NULL
and	NULL
in	NULL
its	NULL
stability	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
GTP	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
experiments	NULL
revealed	NULL
that	NULL
both	NULL
homomeric	NULL
and	NULL
heteromeric	NULL
pS0OB	NULL
complexes	NULL
are	NULL
fairly	NULL
stable	NULL
,	NULL
at	NULL
least	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GTP	NULL
.	NULL

p50B/p97	NULL
and	NULL
RelB	NULL
form	NULL
heteromeric	NULL
complexes	NULL
independent	NULL
of	NULL
DNA	NULL
.	NULL

In	NULL
view	NULL
of	NULL
the	NULL
potential	NULL
for	NULL
RelB	NULL
and	NULL
p50B	NULL
to	NULL
associate	NULL
on	NULL
DNA	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
various	NULL
different	NULL
truncated	NULL
products	NULL
of	NULL
p50B/p97	NULL
could	NULL
form	NULL
heteromeric	NULL
complexes	NULL
with	NULL
RelB	NULL
in	NULL
solution	NULL
without	NULL
DNA	NULL
and	NULL
,	NULL
if	NULL
so	NULL
,	NULL
whether	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
repeats	NULL
prevented	NULL
the	NULL
formation	NULL
of	NULL
such	NULL
complexes	NULL
.	NULL

Blocking	NULL
a	NULL
protein-protein	NULL
interaction	NULL
could	NULL
be	NULL
a	NULL
means	NULL
of	NULL
inhibiting	NULL
DNA	NULL
binding	NULL
by	NULL
the	NULL
repeats	NULL
.	NULL

Full-length	NULL
and	NULL
truncated	NULL
RNAs	NULL
of	NULL
p50B/p97	NULL
were	NULL
cotranslated	NULL
with	NULL
relB	NULL
RNA	NULL
in	NULL
rabbit	NULL
reticulocyte	NULL
lysates	NULL
,	NULL
and	NULL
then	NULL
the	NULL
products	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
RelB	NULL
antibod-ies	NULL
.	NULL

Figure	NULL
6	NULL
shows	NULL
that	NULL
full-length	NULL
p97	NULL
protein	NULL
and	NULL
all	NULL
truncations	NULL
which	NULL
occurred	NULL
carboxy-terminal	NULL
to	NULL
the	NULL
Rel	NULL
domain	NULL
could	NULL
be	NULL
coprecipitated	NULL
with	NULL
RelB	NULL
antibodies	NULL
(	NULL
p97	NULL
FL	NULL
,	NULL
p97	NULL
Nde	NULL
,	NULL
and	NULL
pS50B	NULL
[	NULL
p97	NULL
Sma	NULL
)	NULL
[	NULL
lanes	NULL
6	NULL
,	NULL
10	NULL
and	NULL
14	NULL
,	NULL
respectively	NULL
]	NULL
,	NULL
see	NULL
Fig	NULL
.	NULL

3A	NULL
for	NULL
a	NULL
map	NULL
of	NULL
the	NULL
truncations	NULL
)	NULL
,	NULL
whereas	NULL
a	NULL
truncation	NULL
ending	NULL
within	NULL
but	NULL
near	NULL
the	NULL
end	NULL
of	NULL
the	NULL
Rel-related	NULL
domain	NULL
did	NULL
not	NULL
complex	NULL
with	NULL
RelB	NULL
(	NULL
pS50B	NULL
Afl	NULL
[	NULL
lane	NULL
18	NULL
]	NULL
)	NULL
.	NULL

Figure	NULL
6	NULL
,	NULL
lanes	NULL
5	NULL
,	NULL
9	NULL
,	NULL
13	NULL
,	NULL
and	NULL
17	NULL
,	NULL
shows	NULL
the	NULL
cotranslated	NULL
products	NULL
which	NULL
were	NULL
subjected	NULL
to	NULL
immunopre-cipitation	NULL
.	NULL

RelB	NULL
antibodies	NULL
did	NULL
not	NULL
cross-react	NULL
with	NULL
the	NULL
p50B/p97	NULL
products	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
and	NULL
16	NULL
;	NULL
lanes	NULL
3	NULL
,	NULL
7	NULL
,	NULL
11	NULL
,	NULL
and	NULL
15	NULL
show	NULL
the	NULL
translation	NULL
products	NULL
for	NULL
p50B/p97	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
p50B/p97	NULL
complex	NULL
formation	NULL
with	NULL
RelB	NULL
occurred	NULL
independently	NULL
of	NULL
DNA	NULL
,	NULL
required	NULL
a	NULL
peptide	NULL
sequence	NULL
present	NULL
in	NULL
the	NULL
carboxy-terminal	NULL
end	NULL
of	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
,	NULL
and	NULL
was	NULL
not	NULL
interfered	NULL
with	NULL
by	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
ankyrin	NULL
)	NULL
repeats	NULL
.	NULL

pS50B	NULL
cooperates	NULL
with	NULL
RelB	NULL
and	NULL
with	NULL
p6S	NULL
in	NULL
stimulating	NULL
transcription	NULL
through	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
.	NULL

RelB	NULL
,	NULL
p65	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
692	NULL
BOURS	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
0	NULL
-	NULL
4	NULL
HRS	NULL
TIME	NULL
WIT	NULL
[	NULL
l	NULL
--	NULL
f	NULL
COMPETITOR	NULL
y*	NULL
``	NULL
34/5	NULL
,	NULL
6	NULL
:	NULL
2	NULL
R	NULL
D	NULL
GTP	NULL
0	NULL
-	NULL
4	NULL
HRS	NULL
0	NULL
-	NULL
4	NULL
HRS	NULL
TIME	NULL
WITH	NULL
--	NULL
-	NULL
--	NULL
-	NULL
#	NULL
»	NULL
COMPETITOR	NULL
3	NULL
:	NULL
3	NULL
4	NULL
5	NULL
.	NULL

6	NULL
9	NULL
10	NULL
11	NULL
12	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Stability	NULL
of	NULL
the	NULL
homomeric	NULL
p50B	NULL
(	NULL
A	NULL
)	NULL
or	NULL
the	NULL
heteromeric	NULL
p50B/ReIB	NULL
(	NULL
B	NULL
)	NULL
complexes	NULL
with	NULL
DNA	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
added	NULL
GTP	NULL
(	NULL
5	NULL
mM	NULL
)	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

p50B	NULL
was	NULL
generated	NULL
by	NULL
in	NULL
vitro	NULL
translation	NULL
of	NULL
a	NULL
Smal	NULL
truncation	NULL
of	NULL
pMR-TAGp97	NULL
FL	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
,	NULL
and	NULL
this	NULL
product	NULL
alone	NULL
or	NULL
cotranslated	NULL
with	NULL
RelB	NULL
was	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
the	NULL
palindromic	NULL
probe	NULL
(	NULL
PD-	NULL
«	NULL
kB	NULL
)	NULL
.	NULL

Subsequently	NULL
a	NULL
sample	NULL
was	NULL
removed	NULL
and	NULL
loaded	NULL
on	NULL
a	NULL
gel	NULL
(	NULL
time	NULL
0	NULL
)	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
7	NULL
)	NULL
,	NULL
and	NULL
a	NULL
500-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
was	NULL
added	NULL
to	NULL
the	NULL
remaining	NULL
solution	NULL
.	NULL

Thereafter	NULL
,	NULL
aliquots	NULL
were	NULL
removed	NULL
and	NULL
loaded	NULL
on	NULL
the	NULL
gel	NULL
after	NULL
15	NULL
min	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
8	NULL
)	NULL
,	NULL
30	NULL
min	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
9	NULL
)	NULL
,	NULL
1	NULL
h	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
10	NULL
)	NULL
,	NULL
2	NULL
h	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
11	NULL
)	NULL
,	NULL
and	NULL
4	NULL
h	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
12	NULL
)	NULL
.	NULL

p50B	NULL
were	NULL
each	NULL
cloned	NULL
into	NULL
the	NULL
expression	NULL
vector	NULL
PMT2T	NULL
(	NULL
22	NULL
)	NULL
to	NULL
transiently	NULL
transfect	NULL
NTera-2	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
.	NULL

These	NULL
cells	NULL
have	NULL
little	NULL
or	NULL
no	NULL
endogenous	NULL
NF-	NULL
«	NULL
kB	NULL
activity	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
plasmids	NULL
were	NULL
transfected	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
into	NULL
NTera-2	NULL
cells	NULL
along	NULL
with	NULL
a	NULL
reporter	NULL
plasmid	NULL
,	NULL
HIV-kB	NULL
CAT	NULL
,	NULL
in	NULL
which	NULL
the	NULL
CAT	NULL
gene	NULL
is	NULL
driven	NULL
by	NULL
a	NULL
minimal	NULL
c-fos	NULL
promoter	NULL
dependent	NULL
on	NULL
the	NULL
HIV	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Figure	NULL
7	NULL
shows	NULL
the	NULL
results	NULL
recorded	NULL
as	NULL
the	NULL
average	NULL
of	NULL
three	NULL
to	NULL
five	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

Although	NULL
p50B	NULL
or	NULL
p50	NULL
caused	NULL
little	NULL
or	NULL
no	NULL
expression	NULL
of	NULL
the	NULL
NF-KB	NULL
site-dependent	NULL
reporter	NULL
plasmid	NULL
,	NULL
even	NULL
at	NULL
high	NULL
concentrations	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
p50B	NULL
with	NULL
RelB	NULL
or	NULL
with	NULL
p65	NULL
stimulated	NULL
expression	NULL
well	NULL
beyond	NULL
the	NULL
weaker	NULL
stimulation	NULL
observed	NULL
with	NULL
RelB	NULL
alone	NULL
or	NULL
with	NULL
p65	NULL
alone	NULL
.	NULL

Interestingly	NULL
,	NULL
p50	NULL
and	NULL
pS0B	NULL
were	NULL
approximately	NULL
equally	NULL
effective	NULL
in	NULL
cooperating	NULL
with	NULL
p65	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
and	NULL
with	NULL
RelB	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
the	NULL
transfected	NULL
DNAs	NULL
were	NULL
chosen	NULL
for	NULL
optimal	NULL
levels	NULL
of	NULL
cooperation	NULL
.	NULL

p6S	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

alone	NULL
at	NULL
higher	NULL
concentrations	NULL
transactivated	NULL
increasingly	NULL
well	NULL
by	NULL
itself	NULL
,	NULL
whereas	NULL
RelB	NULL
alone	NULL
transactivated	NULL
only	NULL
weakly	NULL
even	NULL
at	NULL
high	NULL
concentrations	NULL
.	NULL

The	NULL
results	NULL
may	NULL
imply	NULL
that	NULL
p65	NULL
and	NULL
RelB	NULL
harbor	NULL
a	NULL
transactivation	NULL
domain	NULL
and	NULL
that	NULL
p50	NULL
and	NULL
p50B	NULL
provide	NULL
high-affinity	NULL
DNA	NULL
binding	NULL
(	NULL
34	NULL
,	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

As	NULL
a	NULL
further	NULL
control	NULL
for	NULL
these	NULL
experiments	NULL
,	NULL
a	NULL
reporter	NULL
plasmid	NULL
containing	NULL
two	NULL
mutant	NULL
«	NULL
B	NULL
sites	NULL
was	NULL
not	NULL
transacti-vated	NULL
,	NULL
supporting	NULL
the	NULL
conclusion	NULL
that	NULL
the	NULL
observed	NULL
positive	NULL
transactivations	NULL
were	NULL
mediated	NULL
through	NULL
the	NULL
KB	NULL
site	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
the	NULL
HIV-	NULL
«	NULL
kB	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
alone	NULL
resulted	NULL
in	NULL
CAT	NULL
values	NULL
that	NULL
were	NULL
not	NULL
significantly	NULL
higher	NULL
than	NULL
background	NULL
levels	NULL
in	NULL
untransfected	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
cells	NULL
had	NULL
little	NULL
or	NULL
no	NULL
intrinsic	NULL
NF-KB	NULL
activity	NULL
(	NULL
see	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

In	NULL
additional	NULL
experiments	NULL
we	NULL
observed	NULL
cooperation	NULL
in	NULL
transactivation	NULL
between	NULL
p97	NULL
and	NULL
ReIB	NULL
at	NULL
higher	NULL
concentrations	NULL
of	NULL
transfected	NULL
DNAs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
full-length	NULL
p97	NULL
protein	NULL
was	NULL
processed	NULL
in	NULL
vivo	NULL
into	NULL
an	NULL
active	NULL
form	NULL
equivalent	NULL
to	NULL
p50B	NULL
,	NULL
which	NULL
would	NULL
account	NULL
for	NULL
this	NULL
result	NULL
.	NULL

DISCUSSION	NULL
This	NULL
report	NULL
describes	NULL
the	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
mitogen-inducible	NULL
gene	NULL
product	NULL
which	NULL
is	NULL
closely	NULL
related	NULL
to	NULL
the	NULL
p105	NULL
precursor	NULL
protein	NULL
for	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
the	NULL
classical	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
complex	NULL
.	NULL

We	NULL
have	NULL
chosen	NULL
the	NULL
descriptive	NULL
name	NULL
p50B/p97	NULL
because	NULL
of	NULL
functional	NULL
and	NULL
structural	NULL
similarity	NULL
with	NULL
p50/p105-NF-	NULL
«	NULL
B	NULL
.	NULL

By	NULL
analogy	NULL
with	NULL
p50-NF-	NULL
«	NULL
B	NULL
,	NULL
pS50B	NULL
is	NULL
the	NULL
truncated	NULL
form	NULL
of	NULL
the	NULL
p97	NULL
protein	NULL
,	NULL
including	NULL
the	NULL
amino-terminal	NULL
Rel-related	NULL
domain	NULL
but	NULL
excluding	NULL
the	NULL
carboxy-terminal	NULL
cell	NULL
cycle	NULL
(	NULL
ankyrin	NULL
)	NULL
repeats	NULL
.	NULL

Like	NULL
p50	NULL
,	NULL
p50B	NULL
binds	NULL
«	NULL
B	NULL
sites	NULL
,	NULL
forms	NULL
heteromeric	NULL
complexes	NULL
with	NULL
p65	NULL
and	NULL
RelB	NULL
,	NULL
and	NULL
synergizes	NULL
with	NULL
these	NULL
proteins	NULL
in	NULL
transactivating	NULL
through	NULL
a	NULL
«	NULL
B	NULL
site	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
rel	NULL
gene	NULL
family	NULL
can	NULL
now	NULL
be	NULL
divided	NULL
into	NULL
two	NULL
distinct	NULL
groups	NULL
,	NULL
members	NULL
of	NULL
one	NULL
encoding	NULL
cell	NULL
cycle	NULL
(	NULL
ankyrin	NULL
)	NULL
repeats	NULL
(	NULL
including	NULL
p50/p105	NULL
and	NULL
pS50B/p97	NULL
)	NULL
and	NULL
members	NULL
of	NULL
the	NULL
other	NULL
without	NULL
such	NULL
repeats	NULL
(	NULL
including	NULL
c-re/	NULL
,	NULL
p65	NULL
,	NULL
relB	NULL
[	NULL
39	NULL
]	NULL
,	NULL
and	NULL
dorsal	NULL
)	NULL
.	NULL

We	NULL
cloned	NULL
both	NULL
p50/p105	NULL
(	NULL
clone	NULL
243	NULL
)	NULL
and	NULL
p50B/p97	NULL
(	NULL
clone	NULL
189	NULL
)	NULL
as	NULL
cDNAs	NULL
from	NULL
a	NULL
subtracted	NULL
library	NULL
enriched	NULL
for	NULL
genes	NULL
which	NULL
are	NULL
mitogenically	NULL
induced	NULL
at	NULL
an	NULL
early	NULL
time	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
cells	NULL
(	NULL
6	NULL
,	NULL
21	NULL
,	NULL
50	NULL
)	NULL
.	NULL

The	NULL
mRNAs	NULL
of	NULL
both	NULL
genes	NULL
have	NULL
similar	NULL
kinetics	NULL
of	NULL
induction	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
relB	NULL
and	NULL
c-rel	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
inhibitor	NULL
IxB-encoding	NULL
gene	NULL
,	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
early	NULL
response	NULL
genes	NULL
(	NULL
8	NULL
,	NULL
18	NULL
,	NULL
39	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B-like	NULL
activity	NULL
in	NULL
cells	NULL
is	NULL
therefore	NULL
likely	NULL
to	NULL
be	NULL
controlled	NULL
by	NULL
transcriptional	NULL
as	NULL
well	NULL
as	NULL
posttrans-lational	NULL
events	NULL
.	NULL

The	NULL
transcriptional	NULL
regulation	NULL
of	NULL
Rel-related	NULL
and	NULL
inhibitory	NULL
genes	NULL
may	NULL
be	NULL
coordinated	NULL
during	NULL
cellular	NULL
activation	NULL
.	NULL

That	NULL
all	NULL
these	NULL
genes	NULL
are	NULL
rapidly	NULL
inducible	NULL
in	NULL
their	NULL
expression	NULL
demonstrates	NULL
further	NULL
that	NULL
immediate-early	NULL
activation	NULL
genes	NULL
include	NULL
many	NULL
important	NULL
regulatory	NULL
proteins	NULL
which	NULL
are	NULL
central	NULL
to	NULL
the	NULL
decision-making	NULL
processes	NULL
leading	NULL
to	NULL
proliferation	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
differentiated	NULL
pheno-type	NULL
.	NULL

The	NULL
amino-terminal	NULL
Rel-homologous	NULL
domain	NULL
and	NULL
the	NULL
carboxy-terminal	NULL
cell	NULL
cycle	NULL
(	NULL
ankyrin	NULL
)	NULL
repeat	NULL
domain	NULL
of	NULL
p50/p97	NULL
are	NULL
separated	NULL
by	NULL
a	NULL
glycine-rich	NULL
stretch	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
an	NULL
analogous	NULL
glycine-rich	NULL
region	NULL
in	NULL
the	NULL
p50	NULL
precursor	NULL
protein	NULL
contains	NULL
a	NULL
proteolytic	NULL
cleavage	NULL
site	NULL
for	NULL
processing	NULL
(	NULL
37	NULL
)	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
likely	NULL
that	NULL
p97	NULL
is	NULL
processed	NULL
into	NULL
a	NULL
protein	NULL
of	NULL
about	NULL
50	NULL
kDa	NULL
as	NULL
well	NULL
(	NULL
pS0OB	NULL
)	NULL
,	NULL
and	NULL
preliminary	NULL
findings	NULL
in	NULL
our	NULL
laboratory	NULL
support	NULL
this	NULL
(	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

A	NULL
previous	NULL
report	NULL
has	NULL
identified	NULL
several	NULL
Rel-related	NULL
kB	NULL
DNA-binding	NULL
proteins	NULL
detectable	NULL
by	NULL
UV	NULL
cross-linking	NULL
,	NULL
proteins	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
RelB-AB	NULL
AB	NULL
+	NULL
RelB-AB	NULL
C	NULL
+	NULL
RelB	NULL
+	NULL
Relf	NULL
Re	NULL
RelB	NULL
+	NULL
ReIB	NULL
p97	NULL
FL	NULL
p97	NULL
FL	NULL
FL	NULL
7	NULL
Nde	NULL
p97	NULL
Nde	NULL
+	NULL
ReIB	NULL
RelB	NULL
P50B/p97	NULL
,	NULL
A	NULL
NEW	NULL
PROTEIN	NULL
RELATED	NULL
TO	NULL
r50/p105-NF-	NULL
«	NULL
B	NULL
p97	NULL
Nde	NULL
+	NULL
RelB	NULL
H	NULL
693	NULL
RelB-AB	NULL
p97	NULL
Nde	NULL
+	NULL
ReIB	NULL
+	NULL
F	NULL
p508B	NULL
(	NULL
p97	NULL
C	NULL
C	NULL
>	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Coimmunoprecipitation	NULL
of	NULL
pS0B/p97	NULL
and	NULL
RelB	NULL
.	NULL

Lanes	NULL
on	NULL
the	NULL
SDS-PAGE	NULL
gel	NULL
contain	NULL
[	NULL
**S	NULL
)	NULL
methionine-labeled	NULL
in	NULL
vitro	NULL
translation	NULL
products	NULL
of	NULL
the	NULL
templates	NULL
translated	NULL
alone	NULL
and	NULL
in	NULL
combination	NULL
as	NULL
indicated	NULL
(	NULL
RelB	NULL
,	NULL
full-length	NULL
TAGp97	NULL
,	NULL
and	NULL
various	NULL
truncations	NULL
thereof	NULL
)	NULL
.	NULL

See	NULL
Fig	NULL
.	NULL

3C	NULL
and	NULL
D	NULL
for	NULL
p50B/p97	NULL
constructs	NULL
used	NULL
and	NULL
Fig	NULL
.	NULL

3A	NULL
for	NULL
a	NULL
map	NULL
of	NULL
the	NULL
truncations	NULL
.	NULL

Odd-numbered	NULL
lanes	NULL
contain	NULL
the	NULL
translation	NULL
products	NULL
;	NULL
even-numbered	NULL
lanes	NULL
contain	NULL
the	NULL
products	NULL
recovered	NULL
following	NULL
immunoprecipitation	NULL
with	NULL
RelB	NULL
antibody	NULL
(	NULL
AB	NULL
)	NULL
.	NULL

with	NULL
molecular	NULL
masses	NULL
of	NULL
50	NULL
,	NULL
55	NULL
,	NULL
75	NULL
,	NULL
and	NULL
85	NULL
kDa	NULL
,	NULL
the	NULL
last	NULL
of	NULL
these	NULL
being	NULL
c-Rel	NULL
(	NULL
5	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
an	NULL
in	NULL
vivo-processed	NULL
form	NULL
of	NULL
p97	NULL
corresponds	NULL
to	NULL
the	NULL
50-	NULL
or	NULL
55-kDa	NULL
species	NULL
,	NULL
although	NULL
the	NULL
authors	NULL
speculated	NULL
that	NULL
these	NULL
two	NULL
proteins	NULL
may	NULL
be	NULL
related	NULL
to	NULL
each	NULL
other	NULL
and	NULL
correspond	NULL
to	NULL
the	NULL
p5O/kBF-1	NULL
subunit	NULL
of	NULL
the	NULL
classical	NULL
NF-kB	NULL
complex	NULL
.	NULL

140	NULL
120	NULL
4	NULL
100	NULL
7	NULL
80	NULL
7	NULL
40	NULL
7	NULL
FOLD	NULL
INDUCTION	NULL
20	NULL
7	NULL
o	NULL
<	NULL
I	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7T	NULL
FIG	NULL
.	NULL

7.	NULL
p50B	NULL
together	NULL
with	NULL
ReIB	NULL
or	NULL
p65	NULL
stimulates	NULL
transcription	NULL
in	NULL
vivo	NULL
of	NULL
a	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
dependent	NULL
on	NULL
a	NULL
«	NULL
B	NULL
site	NULL
(	NULL
HIV-	NULL
«	NULL
kB	NULL
CAT	NULL
;	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
cell	NULL
extracts	NULL
of	NULL
NTera-2	NULL
cells	NULL
after	NULL
transfection	NULL
with	NULL
constructs	NULL
expressing	NULL
p50B	NULL
,	NULL
p50	NULL
,	NULL
RelB	NULL
,	NULL
or	NULL
p65	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
transfected	NULL
separately	NULL
or	NULL
together	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
the	NULL
fold	NULL
induction	NULL
observed	NULL
over	NULL
the	NULL
activity	NULL
produced	NULL
by	NULL
a	NULL
transfection	NULL
with	NULL
the	NULL
HIV-	NULL
«	NULL
xB	NULL
CAT	NULL
vector	NULL
alone	NULL
.	NULL

The	NULL
fold	NULL
induction	NULL
values	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
to	NULL
five	NULL
independent	NULL
transfections	NULL
after	NULL
normalizing	NULL
to	NULL
the	NULL
protein	NULL
concentrations	NULL
of	NULL
the	NULL
cellular	NULL
extracts	NULL
.	NULL

Transfections	NULL
involving	NULL
RelB	NULL
were	NULL
done	NULL
separately	NULL
from	NULL
those	NULL
involving	NULL
p65	NULL
.	NULL

The	NULL
absolute	NULL
counts	NULL
obtained	NULL
from	NULL
the	NULL
transfection	NULL
of	NULL
the	NULL
CAT	NULL
vector	NULL
alone	NULL
ranged	NULL
from	NULL
1x	NULL
to	NULL
1.9	NULL
%	NULL
above	NULL
background	NULL
levels	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CAT	NULL
vector	NULL
.	NULL

Amounts	NULL
of	NULL
DNAs	NULL
used	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
0.1	NULL
ug	NULL
of	NULL
RelB	NULL
,	NULL
0.03	NULL
ug	NULL
of	NULL
p65	NULL
,	NULL
0.1	NULL
ug	NULL
of	NULL
p50	NULL
,	NULL
and	NULL
0.1	NULL
ug	NULL
of	NULL
p50B	NULL
.	NULL

For	NULL
p50	NULL
alone	NULL
or	NULL
p50B	NULL
alone	NULL
,	NULL
3	NULL
ug	NULL
was	NULL
transfected	NULL
to	NULL
show	NULL
insignificant	NULL
transactivation	NULL
even	NULL
at	NULL
higher	NULL
DNA	NULL
concentrations	NULL
.	NULL

Tracks	NULL
:	NULL
1	NULL
,	NULL
p50	NULL
;	NULL
2	NULL
,	NULL
p50B	NULL
;	NULL
3	NULL
,	NULL
RelB	NULL
;	NULL
4	NULL
,	NULL
p50B-ReIB	NULL
;	NULL
5	NULL
,	NULL
p65	NULL
;	NULL
6	NULL
,	NULL
p50-p65	NULL
;	NULL
7	NULL
,	NULL
p50B-p65	NULL
.	NULL

The	NULL
Rel-related	NULL
domain	NULL
(	NULL
p5S0OB	NULL
)	NULL
is	NULL
responsible	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
for	NULL
protein-protein	NULL
interaction	NULL
to	NULL
form	NULL
homomeric	NULL
or	NULL
heteromeric	NULL
complexes	NULL
.	NULL

The	NULL
association	NULL
between	NULL
RelB	NULL
and	NULL
p50B	NULL
depends	NULL
on	NULL
the	NULL
carboxy-terminal	NULL
portion	NULL
of	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
.	NULL

Truncations	NULL
removing	NULL
this	NULL
amino	NULL
acid	NULL
sequence	NULL
abolish	NULL
the	NULL
interaction	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
preliminary	NULL
observations	NULL
of	NULL
site-directed	NULL
mutations	NULL
in	NULL
the	NULL
analogous	NULL
region	NULL
of	NULL
the	NULL
p50	NULL
protein	NULL
which	NULL
ablate	NULL
dimerization	NULL
(	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

A	NULL
recent	NULL
report	NULL
demonstrating	NULL
that	NULL
a	NULL
deletion	NULL
of	NULL
the	NULL
amino-terminal	NULL
half	NULL
of	NULL
the	NULL
Rel	NULL
domain	NULL
of	NULL
p50	NULL
can	NULL
still	NULL
form	NULL
dimers	NULL
is	NULL
in	NULL
accord	NULL
with	NULL
our	NULL
findings	NULL
(	NULL
29	NULL
)	NULL
.	NULL

As	NULL
observed	NULL
for	NULL
the	NULL
p105	NULL
precursor	NULL
protein	NULL
of	NULL
p50	NULL
,	NULL
the	NULL
carboxy-terminal	NULL
repeat	NULL
domain	NULL
of	NULL
p97	NULL
apparently	NULL
inhibits	NULL
DNA	NULL
binding	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
this	NULL
domain	NULL
does	NULL
not	NULL
interfere	NULL
with	NULL
dimerization	NULL
,	NULL
at	NULL
least	NULL
not	NULL
with	NULL
RelB	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
inhibitory	NULL
activity	NULL
inherent	NULL
in	NULL
the	NULL
repeat	NULL
domain	NULL
may	NULL
be	NULL
directed	NULL
at	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
pS50B/p97	NULL
rather	NULL
than	NULL
the	NULL
dimerization	NULL
domain	NULL
;	NULL
a	NULL
similar	NULL
scenario	NULL
is	NULL
likely	NULL
for	NULL
the	NULL
p50	NULL
precursor	NULL
.	NULL

The	NULL
very	NULL
recent	NULL
discovery	NULL
that	NULL
IxB	NULL
proteins	NULL
contain	NULL
repeats	NULL
confirms	NULL
such	NULL
a	NULL
view	NULL
(	NULL
10	NULL
,	NULL
18	NULL
)	NULL
.	NULL

The	NULL
IxB	NULL
protein	NULL
is	NULL
thought	NULL
to	NULL
inhibit	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
p65	NULL
but	NULL
not	NULL
its	NULL
dimerization	NULL
potential	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
repeats	NULL
may	NULL
therefore	NULL
be	NULL
the	NULL
common	NULL
denominator	NULL
for	NULL
all	NULL
proteins	NULL
which	NULL
have	NULL
as	NULL
a	NULL
functional	NULL
target	NULL
the	NULL
DNA-binding	NULL
domains	NULL
present	NULL
in	NULL
the	NULL
Rel	NULL
homology	NULL
regions	NULL
of	NULL
the	NULL
various	NULL
proteins	NULL
.	NULL

This	NULL
does	NULL
not	NULL
rule	NULL
out	NULL
other	NULL
possible	NULL
functions	NULL
of	NULL
the	NULL
carboxy-terminal	NULL
half	NULL
of	NULL
p97	NULL
and	NULL
p105	NULL
.	NULL

For	NULL
example	NULL
,	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
the	NULL
repeats	NULL
may	NULL
mediate	NULL
an	NULL
interaction	NULL
of	NULL
these	NULL
proteins	NULL
with	NULL
cytoskeletal	NULL
structures	NULL
(	NULL
6	NULL
,	NULL
18	NULL
,	NULL
30	NULL
)	NULL
.	NULL

p50B	NULL
does	NULL
not	NULL
possess	NULL
a	NULL
protein	NULL
kinase	NULL
A	NULL
phosphorylation	NULL
site	NULL
near	NULL
its	NULL
nuclear	NULL
translocation	NULL
signal	NULL
sequence	NULL
.	NULL

This	NULL
distinguishes	NULL
p50B	NULL
from	NULL
the	NULL
other	NULL
Rel-related	NULL
proteins	NULL
described	NULL
to	NULL
date	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
ReIB	NULL
(	NULL
39	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
the	NULL
putative	NULL
protein	NULL
kinase	NULL
A	NULL
site	NULL
present	NULL
in	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
Dorsal	NULL
is	NULL
physiologically	NULL
significant	NULL
,	NULL
but	NULL
if	NULL
it	NULL
is	NULL
,	NULL
one	NULL
could	NULL
envision	NULL
a	NULL
role	NULL
in	NULL
nuclear	NULL
translocation	NULL
and/or	NULL
function	NULL
of	NULL
these	NULL
proteins	NULL
.	NULL

694	NULL
BOURS	NULL
ET	NULL
AL	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
a	NULL
heteromeric	NULL
complex	NULL
between	NULL
p50	NULL
and	NULL
RelB	NULL
by	NULL
immunoprecipitations	NULL
in	NULL
solution	NULL
,	NULL
by	NULL
EM-SAs	NULL
,	NULL
and	NULL
by	NULL
antibody-mediated	NULL
supershifts	NULL
in	NULL
EMSAs	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
complex	NULL
can	NULL
exist	NULL
which	NULL
does	NULL
not	NULL
involve	NULL
the	NULL
p50	NULL
or	NULL
the	NULL
p65	NULL
protein	NULL
,	NULL
the	NULL
constituents	NULL
of	NULL
the	NULL
classical	NULL
,	NULL
biochemically	NULL
described	NULL
kB-binding	NULL
complex	NULL
,	NULL
or	NULL
the	NULL
c-Rel	NULL
protein	NULL
.	NULL

Furthermore	NULL
,	NULL
p50B	NULL
in	NULL
concert	NULL
with	NULL
RelB	NULL
transactivated	NULL
a	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
critically	NULL
dependent	NULL
on	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
.	NULL

The	NULL
RelB	NULL
protein	NULL
was	NULL
a	NULL
necessary	NULL
partner	NULL
to	NULL
demonstrate	NULL
a	NULL
strong	NULL
transactivation	NULL
by	NULL
p50B	NULL
in	NULL
NTera-2	NULL
cells	NULL
,	NULL
which	NULL
have	NULL
little	NULL
to	NULL
no	NULL
intrinsic	NULL
NF-kB	NULL
activity	NULL
.	NULL

The	NULL
functional	NULL
cooperation	NULL
extends	NULL
and	NULL
confirms	NULL
the	NULL
in	NULL
vitro	NULL
data	NULL
on	NULL
the	NULL
novel	NULL
NF-	NULL
«	NULL
B-like	NULL
complex	NULL
formed	NULL
by	NULL
p50B	NULL
and	NULL
RelB	NULL
.	NULL

p50B	NULL
also	NULL
cooperated	NULL
with	NULL
p65	NULL
in	NULL
transactivating	NULL
through	NULL
a	NULL
«	NULL
B	NULL
site	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
extent	NULL
of	NULL
the	NULL
cooperation	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
pSO0	NULL
.	NULL

This	NULL
suggests	NULL
a	NULL
functional	NULL
similarity	NULL
between	NULL
p50	NULL
and	NULL
p5S0B	NULL
.	NULL

The	NULL
data	NULL
indicate	NULL
that	NULL
a	NULL
family	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
complexes	NULL
can	NULL
exist	NULL
in	NULL
cells	NULL
.	NULL

These	NULL
complexes	NULL
may	NULL
perform	NULL
subtly	NULL
different	NULL
functions	NULL
and/or	NULL
may	NULL
be	NULL
responsive	NULL
to	NULL
different	NULL
signals	NULL
.	NULL

They	NULL
may	NULL
also	NULL
be	NULL
cell	NULL
type	NULL
specific	NULL
,	NULL
possibly	NULL
depending	NULL
on	NULL
the	NULL
amounts	NULL
of	NULL
the	NULL
various	NULL
constituents	NULL
present	NULL
.	NULL

Further	NULL
experiments	NULL
are	NULL
needed	NULL
to	NULL
determine	NULL
in	NULL
vivo	NULL
which	NULL
complexes	NULL
exist	NULL
in	NULL
a	NULL
given	NULL
cellular	NULL
milieu	NULL
,	NULL
what	NULL
their	NULL
specific	NULL
functions	NULL
are	NULL
,	NULL
and	NULL
how	NULL
they	NULL
are	NULL
regulated	NULL
.	NULL

In	NULL
vitro	NULL
experiments	NULL
showed	NULL
that	NULL
binding	NULL
of	NULL
heteromeric	NULL
complexes	NULL
between	NULL
p50B	NULL
and	NULL
RelB	NULL
or	NULL
p65	NULL
was	NULL
increased	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
GTP	NULL
,	NULL
as	NULL
was	NULL
the	NULL
stability	NULL
of	NULL
these	NULL
complexes	NULL
when	NULL
challenged	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
kB	NULL
sites	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
GTP	NULL
on	NULL
the	NULL
homomeric	NULL
p50B	NULL
complex	NULL
was	NULL
primarily	NULL
one	NULL
of	NULL
stabilizing	NULL
the	NULL
complex	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
competitive	NULL
binding	NULL
sites	NULL
.	NULL

GTP	NULL
has	NULL
been	NULL
previously	NULL
recognized	NULL
to	NULL
increase	NULL
the	NULL
binding	NULL
of	NULL
p50/p65	NULL
or	NULL
of	NULL
p50/p50	NULL
to	NULL
DNA	NULL
(	NULL
4	NULL
,	NULL
28	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
GTP	NULL
effect	NULL
seen	NULL
in	NULL
vitro	NULL
reflects	NULL
a	NULL
physiologically	NULL
relevant	NULL
phenomenon	NULL
;	NULL
however	NULL
,	NULL
it	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
a	NULL
ligand-induced	NULL
change	NULL
in	NULL
binding	NULL
occurs	NULL
in	NULL
vivo	NULL
.	NULL

Our	NULL
data	NULL
with	NULL
p50B	NULL
imply	NULL
that	NULL
responsiveness	NULL
to	NULL
GTP	NULL
is	NULL
not	NULL
a	NULL
unique	NULL
property	NULL
of	NULL
the	NULL
p5O/kBF-1	NULL
subunit	NULL
of	NULL
NF-kB	NULL
.	NULL

After	NULL
the	NULL
initial	NULL
completion	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction-mediated	NULL
cloning	NULL
of	NULL
a	NULL
gene	NULL
which	NULL
appears	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
pS0B/p97	NULL
was	NULL
reported	NULL
(	NULL
40	NULL
)	NULL
.	NULL

We	NULL
note	NULL
several	NULL
sequence	NULL
differences	NULL
which	NULL
include	NULL
changes	NULL
of	NULL
the	NULL
protein	NULL
structure	NULL
in	NULL
two	NULL
extended	NULL
regions	NULL
(	NULL
see	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
the	NULL
reported	NULL
shorter	NULL
alternatively	NULL
spliced	NULL
mRNA	NULL
in	NULL
our	NULL
cells	NULL
,	NULL
which	NULL
included	NULL
primary	NULL
lymphocytes	NULL
.	NULL

In	NULL
accord	NULL
with	NULL
their	NULL
data	NULL
,	NULL
we	NULL
did	NULL
observe	NULL
cooperation	NULL
between	NULL
p50B	NULL
(	NULL
their	NULL
p49	NULL
protein	NULL
)	NULL
and	NULL
p65	NULL
.	NULL

However	NULL
,	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
the	NULL
reported	NULL
dramatic	NULL
difference	NULL
in	NULL
transactivation	NULL
between	NULL
p50B	NULL
(	NULL
their	NULL
p49	NULL
)	NULL
and	NULL
p50	NULL
.	NULL

In	NULL
our	NULL
assay	NULL
system	NULL
p50	NULL
cooperated	NULL
at	NULL
least	NULL
as	NULL
well	NULL
as	NULL
p50B	NULL
did	NULL
with	NULL
either	NULL
p65	NULL
or	NULL
RelB	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Mitchell	NULL
Rosner	NULL
and	NULL
Louis	NULL
Staudt	NULL
for	NULL
the	NULL
pMR-TAG	NULL
vector	NULL
,	NULL
Michael	NULL
Lenardo	NULL
for	NULL
the	NULL
J32	NULL
plasmid	NULL
,	NULL
Craig	NULL
Rosen	NULL
for	NULL
the	NULL
human	NULL
p65	NULL
plasmid	NULL
,	NULL
and	NULL
Keiko	NULL
Ozato	NULL
for	NULL
NTera-2	NULL
cells	NULL
and	NULL
the	NULL
transfection	NULL
protocol	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Lisa	NULL
Winston	NULL
for	NULL
her	NULL
experimental	NULL
help	NULL
and	NULL
to	NULL
Mary	NULL
Rust	NULL
for	NULL
help	NULL
with	NULL
the	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
are	NULL
most	NULL
grateful	NULL
to	NULL
Anthony	NULL
S.	NULL
Fauci	NULL
for	NULL
support	NULL
and	NULL
encouragement	NULL
and	NULL
for	NULL
reviewing	NULL
the	NULL
manuscript	NULL
.	NULL

Vincent	NULL
Bours	NULL
is	NULL
a	NULL
Senior	NULL
Research	NULL
Assistant	NULL
of	NULL
the	NULL
Belgian	NULL
National	NULL
Fund	NULL
for	NULL
Scientific	NULL
Research	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Andrews	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
and	NULL
I.	NULL
Herskowitz	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
yeast	NULL
SW14	NULL
protein	NULL
contains	NULL
a	NULL
motif	NULL
present	NULL
in	NULL
developmental	NULL
regulators	NULL
and	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bio..	NULL
is	NULL
part	NULL
of	NULL
a	NULL
complex	NULL
involved	NULL
in	NULL
cell-cycle-dependent	NULL
transcrip-tion	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
342:830-833.	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
activator	NULL
NF-kB	NULL
:	NULL
regulation	NULL
by	NULL
distinct	NULL
protein	NULL
subunits	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072:63-80.	NULL
.	NULL

Baeverle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IxB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540-546.	NULL
.	NULL

Baeverle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
65	NULL
kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-KB	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
IxB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1689-1698.	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
W.	NULL
H.	NULL
Walker	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
P.	NULL
Sista	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Molitor	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
N.	NULL
J.	NULL
Peffer	NULL
,	NULL
M.	NULL
Hanninck	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
v-re	NULL
!	NULL

oncogene	NULL
encodes	NULL
a	NULL
xB	NULL
enhancer	NULL
binding	NULL
protein	NULL
that	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
function	NULL
.	NULL

Cell	NULL
63:803-814.	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
mitogen-inducible	NULL
gene	NULL
encoding	NULL
a	NULL
«	NULL
B	NULL
DNA-binding	NULL
protein	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
and	NULL
to	NULL
cell-cycle	NULL
motifs	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
348:76-80.	NULL
.	NULL

Brownell	NULL
,	NULL
E.	NULL
,	NULL
N.	NULL
Mittereder	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
human	NULL
rel	NULL
proto-oncogene	NULL
cDNA	NULL
containing	NULL
an	NULL
Alu	NULL
fragment	NULL
as	NULL
a	NULL
potential	NULL
coding	NULL
exon	NULL
.	NULL

Oncogene	NULL
4:935-942.	NULL
.	NULL

Bull	NULL
,	NULL
P.	NULL
,	NULL
T.	NULL
Hunter	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1989	NULL
.	NULL

Transcriptional	NULL
induction	NULL
of	NULL
the	NULL
murine	NULL
c-re/	NULL
gene	NULL
with	NULL
serum	NULL
and	NULL
phorbol-12-myristate-13-acetate	NULL
in	NULL
fibroblasts	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:5239-5243.	NULL
.	NULL

Capobianco	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
D.	NULL
L.	NULL
Simmons	NULL
,	NULL
and	NULL
T.	NULL
D.	NULL
Gilmore	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
and	NULL
expression	NULL
of	NULL
a	NULL
chicken	NULL
c-re/	NULL
cDNA	NULL
:	NULL
unlike	NULL
p59	NULL
``	NULL
,	NULL
p68®	NULL
``	NULL
``	NULL
``	NULL
is	NULL
a	NULL
cytoplasmic	NULL
protein	NULL
in	NULL
chicken	NULL
embryo	NULL
fibroblasts	NULL
.	NULL

Oncogene	NULL
5:257-265	NULL
.	NULL

Davis	NULL
,	NULL
N.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
D.	NULL
L.	NULL
Simmons	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
H.	NULL
R.	NULL
Bose	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Rel-associated	NULL
pp40	NULL
:	NULL
an	NULL
inhibitor	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
of	NULL
transcriptional	NULL
factors	NULL
.	NULL

Science	NULL
253:1268-1271	NULL
.	NULL

Field	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
Nikawa	NULL
,	NULL
D.	NULL
Broek	NULL
,	NULL
B.	NULL
MacDonald	NULL
,	NULL
L.	NULL
Rodgers	NULL
,	NULL
I	NULL
.	NULL

A.	NULL
Wilson	NULL
,	NULL
R.	NULL
A.	NULL
Lerner	NULL
,	NULL
and	NULL
M.	NULL
Wigler	NULL
,	NULL
1988	NULL
.	NULL

Purification	NULL
of	NULL
a	NULL
RAS-responsive	NULL
adenylcyclase	NULL
complex	NULL
from	NULL
Saccharomyces	NULL
cerevisiae	NULL
by	NULL
use	NULL
of	NULL
an	NULL
epitope	NULL
addition	NULL
method	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:2159-2165	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
in	NULL
vitro	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
inhibitor	NULL
IxB	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344	NULL
:	NULL
678-682	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
M.	NULL
Gifford	NULL
,	NULL
L.	NULL
R.	NULL
Riviere	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-kB	NULL
:	NULL
homology	NULL
to	NULL
rel	NULL
and	NULL
dorsal	NULL
.	NULL

Cell	NULL
62:1019-1029	NULL
.	NULL

Gilman	NULL
,	NULL
M.	NULL
Z.	NULL
,	NULL
R.	NULL
N.	NULL
Wilson	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Weinberg	NULL
.	NULL

1986	NULL
.	NULL

Multiple	NULL
protein-binding	NULL
sites	NULL
in	NULL
the	NULL
5'-flanking	NULL
region	NULL
regulate	NULL
c-fos	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6:4305-4316	NULL
.	NULL

Gilmore	NULL
,	NULL
T.	NULL
D.	NULL
,	NULL
and	NULL
H.	NULL
M.	NULL
Temin	NULL
.	NULL

1988.	NULL
v-re/	NULL
oncoproteins	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
in	NULL
the	NULL
cytoplasm	NULL
transform	NULL
chicken	NULL
spleen	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62:703-714	NULL
.	NULL

Grumont	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
S.	NULL
Gerondakis	NULL
.	NULL

1989	NULL
.	NULL

Structure	NULL
of	NULL
a	NULL
mammalian	NULL
c-rel	NULL
protein	NULL
deduced	NULL
from	NULL
the	NULL
nucleotide	NULL
sequence	NULL
of	NULL
murine	NULL
cDNA	NULL
clones	NULL
.	NULL

Oncogene	NULL
Res	NULL
.	NULL

4:1-8	NULL
.	NULL

Hannink	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
H.	NULL
M.	NULL
Temin	NULL
.	NULL

1989	NULL
.	NULL

Transactivation	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
rel	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:4323-4336	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Beg	NULL
,	NULL
S.	NULL
M.	NULL
Tompkins	NULL
,	NULL
J.	NULL
S.	NULL
Morris	NULL
,	NULL
A.	NULL
D.	NULL
Yurochko	NULL
,	NULL
A.	NULL
Sampson-Johannes	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281-1289	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
D.	NULL
Kerr	NULL
,	NULL
L.	NULL
J.	NULL
Ransone	NULL
,	NULL
E.	NULL
Bengal	NULL
,	NULL
T.	NULL
Hunter	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1991.	NULL
activates	NULL
but	NULL
v-rel	NULL
suppresses	NULL
transcription	NULL
from	NULL
«	NULL
B	NULL
sites	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:3715-3719	NULL
.	NULL

Ip	NULL
,	NULL
Y.	NULL
T.	NULL
,	NULL
R.	NULL
Kraut	NULL
,	NULL
M.	NULL
Levin	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rushlow	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
dorsal	NULL
morphogen	NULL
is	NULL
a	NULL
sequence-specific	NULL
DNA-binding	NULL
protein	NULL
that	NULL
interacts	NULL
with	NULL
a	NULL
long-range	NULL
repression	NULL
element	NULL
in	NULL
Droso-phila	NULL
.	NULL

Cell	NULL
64:439-446	NULL
.	NULL

Irving	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
P.	NULL
F.	NULL
Zipfel	NULL
,	NULL
U.	NULL
Siebenlist	NULL
,	NULL
and	NULL
K.	NULL
Kelly	NULL
.	NULL

1989	NULL
.	NULL

Mitogen-induced	NULL
genes	NULL
are	NULL
subject	NULL
to	NULL
multiple	NULL
pathways	NULL
of	NULL
regulation	NULL
in	NULL
the	NULL
initial	NULL
stages	NULL
of	NULL
T-cell	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:1034-1040	NULL
.	NULL

Israel	NULL
,	NULL
D.	NULL
I.	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Kaufman	NULL
.	NULL

1989	NULL
.	NULL

Highly	NULL
inducible	NULL
expression	NULL
from	NULL
vectors	NULL
containing	NULL
multiple	NULL
GRE	NULL
's	NULL
in	NULL
CHO	NULL
cells	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36.	NULL
overexpressing	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:4589-4604	NULL
.	NULL

Kaburn	NULL
,	NULL
N.	NULL
,	NULL
J.	NULL
W.	NULL
Hodgson	NULL
,	NULL
M.	NULL
Doemer	NULL
,	NULL
G.	NULL
Mak	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Enrietto	NULL
.	NULL

1991	NULL
.	NULL

Interaction	NULL
of	NULL
the	NULL
protein	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
xB	NULL
DNA	NULL
binding	NULL
site	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:1783-1787	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
Vandekerckhove	NULL
,	NULL
F.	NULL
Lottspe-ich	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Ball	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018	NULL
.	NULL

Kozak	NULL
,	NULL
M.	NULL
1989	NULL
.	NULL

The	NULL
scanning	NULL
model	NULL
for	NULL
translation	NULL
:	NULL
an	NULL
update	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

108:229-241	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
W.	NULL
Pierce	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

Protein-binding	NULL
sites	NULL
in	NULL
Ig	NULL
enhancers	NULL
determine	NULL
transcriptional	NULL
activity	NULL
and	NULL
inducibility	NULL
.	NULL

Science	NULL
236:1573-1577	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

NF-kB	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58:227-229	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
A.	NULL
Kuang	NULL
,	NULL
A.	NULL
Gifford	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
purification	NULL
from	NULL
bovine	NULL
spleen	NULL
:	NULL
nucleotide	NULL
stimulation	NULL
and	NULL
binding	NULL
site	NULL
specificity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
:	NULL
8825-8829	NULL
.	NULL

Logeat	NULL
,	NULL
F.	NULL
,	NULL
N.	NULL
Israel	NULL
,	NULL
R.	NULL
Ten	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Ball	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1991	NULL
.	NULL

Inhibition	NULL
of	NULL
transcription	NULL
factors	NULL
belonging	NULL
to	NULL
the	NULL
rel/NF-	NULL
«	NULL
B	NULL
family	NULL
by	NULL
a	NULL
transdominant	NULL
negative	NULL
mutant	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:1827-1832	NULL
.	NULL

Lux	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
K.	NULL
M.	NULL
John	NULL
,	NULL
and	NULL
V.	NULL
Bennett	NULL
.	NULL

1990	NULL
.	NULL

Analysis	NULL
of	NULL
cDNA	NULL
for	NULL
human	NULL
erythrocyte	NULL
ankyrin	NULL
indicates	NULL
a	NULL
repeated	NULL
structure	NULL
with	NULL
homology	NULL
to	NULL
tissue-differentiation	NULL
and	NULL
cell-cycle	NULL
control	NULL
proteins	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344:36-42	NULL
.	NULL

Meyer	NULL
,	NULL
R.	NULL
,	NULL
E.	NULL
N.	NULL
Hatada	NULL
,	NULL
H.-P.	NULL
Hohmann	NULL
,	NULL
M.	NULL
Halker	NULL
,	NULL
C.	NULL
Bartsch	NULL
,	NULL
U.	NULL
Rothlisberger	NULL
,	NULL
H.-W.	NULL
Lahm	NULL
,	NULL
E.	NULL
J.	NULL
Schaleger	NULL
,	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
van	NULL
Loon	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
human	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
:	NULL
the	NULL
level	NULL
of	NULL
its	NULL
mRNA	NULL
is	NULL
strongly	NULL
regulated	NULL
by	NULL
phorbol	NULL
ester	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:966-970	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-713	NULL
.	NULL

Neumann	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
C.	NULL
Morency	NULL
,	NULL
and	NULL
K.	NULL
Russian	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
novel	NULL
rapid	NULL
assay	NULL
for	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
expression	NULL
.	NULL

BioTechniques	NULL
5:444-447	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
binding	NULL
and	NULL
IxB	NULL
inhibition	NULL
of	NULL
the	NULL
cloned	NULL
p65	NULL
subunit	NULL
of	NULL
NF-kB	NULL
,	NULL
a	NULL
rel-related	NULL
polypeptide	NULL
.	NULL

Cell	NULL
64:961-969	NULL
.	NULL

Pierce	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
M.	NULL
Lenardo	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Oligonucleotide	NULL
that	NULL
binds	NULL
nuclear	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
acts	NULL
as	NULL
a	NULL
lymphoid-specific	NULL
and	NULL
inducible	NULL
enhancer	NULL
element	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:1482-1486	NULL
.	NULL

Richardson	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
and	NULL
T.	NULL
D.	NULL
Gilmore	NULL
.	NULL

1991.	NULL
vRel	NULL
is	NULL
an	NULL
inactive	NULL
P50B/p97	NULL
,	NULL
A	NULL
NEW	NULL
PROTEIN	NULL
RELATED	NULL
TO	NULL
P50/p105-NF-	NULL
«	NULL
B	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

695	NULL
member	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
of	NULL
transcriptional	NULL
activating	NULL
proteins	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:3122-3130	NULL
.	NULL

Rivicre	NULL
,	NULL
Y.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1991	NULL
.	NULL

Processing	NULL
of	NULL
the	NULL
precursor	NULL
of	NULL
NF-kB	NULL
by	NULL
the	NULL
HIV-1	NULL
protease	NULL
during	NULL
acute	NULL
infection	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
350:625-626	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
rel-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
251:1490-1493	NULL
.	NULL

Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
P.	NULL
Bull	NULL
,	NULL
M.	NULL
Takamiya	NULL
,	NULL
V.	NULL
Bours	NULL
,	NULL
U.	NULL
Siebenlist	NULL
,	NULL
P.	NULL
Dobrzanski	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1992	NULL
.	NULL

RelB	NULL
,	NULL
a	NULL
new	NULL
Rel	NULL
family	NULL
transcription	NULL
activator	NULL
that	NULL
can	NULL
interact	NULL
with	NULL
pS0-NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:674-684.	NULL
.	NULL

Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
P.	NULL
C.	NULL
Andrews	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
which	NULL
stimulates	NULL
HIV	NULL
transcription	NULL
in	NULL
synergy	NULL
with	NULL
p65	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
352:733-736	NULL
.	NULL

Singh	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
Sen	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
a	NULL
conserved	NULL
sequence	NULL
motif	NULL
in	NULL
transcriptional	NULL
control	NULL
elements	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
319:154-158	NULL
.	NULL

Stephens	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
R.	NULL
R.	NULL
Hiebsch	NULL
,	NULL
H.	NULL
R.	NULL
Bose	NULL
,	NULL
and	NULL
R.	NULL
V.	NULL
Gilden	NULL
.	NULL

1983	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
oncogene	NULL
of	NULL
the	NULL
reticuloendotheliosis	NULL
virus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80:6229-6232	NULL
.	NULL

Steward	NULL
,	NULL
R.	NULL
1987	NULL
.	NULL

Dorsal	NULL
,	NULL
an	NULL
embryonic	NULL
polarity	NULL
gene	NULL
in	NULL
Droso-phila	NULL
,	NULL
is	NULL
homologous	NULL
to	NULL
the	NULL
vertebrate	NULL
proto-oncogene	NULL
,	NULL
c-rel	NULL
.	NULL

Science	NULL
238:692-694.	NULL
.	NULL

Tanaka	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1990	NULL
.	NULL

Differential	NULL
transcriptional	NULL
activation	NULL
by	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
:	NULL
interdependent	NULL
domains	NULL
induce	NULL
Oct-2	NULL
phosphorylation	NULL
.	NULL

Cell	NULL
60:375-386	NULL
.	NULL

Thisse	NULL
,	NULL
C.	NULL
,	NULL
F.	NULL
Perrin-Schmitt	NULL
,	NULL
C.	NULL
Stoetzel	NULL
,	NULL
and	NULL
B.	NULL
Thisse	NULL
.	NULL

1991	NULL
.	NULL

Sequence-specific	NULL
transactivation	NULL
of	NULL
the	NULL
Drosophila	NULL
twist	NULL
gene	NULL
by	NULL
the	NULL
dorsal	NULL
gene	NULL
product	NULL
.	NULL

Cell	NULL
65:1191-1201.	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
65	NULL
kD	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
receptor	NULL
for	NULL
IxB	NULL
and	NULL
a	NULL
modulator	NULL
of	NULL
DNA-binding	NULL
specificity	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1975-1984	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1991	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
contacts	NULL
DNA	NULL
by	NULL
a	NULL
heterodimer	NULL
of	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunit	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:1817-1825	NULL
.	NULL

Wilhelmsen	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
K.	NULL
Eggleton	NULL
,	NULL
and	NULL
H.	NULL
M.	NULL
Temin	NULL
.	NULL

1984	NULL
.	NULL

Nucleic	NULL
acid	NULL
sequences	NULL
of	NULL
the	NULL
oncogene	NULL
v-rel	NULL
in	NULL
reticuloendotheliosis	NULL
virus	NULL
strain	NULL
T	NULL
and	NULL
its	NULL
cellular	NULL
homolog	NULL
,	NULL
the	NULL
proto-oncogene	NULL
c-rel	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

52:172-182	NULL
.	NULL

Wright	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
K.	NULL
C.	NULL
Gunter	NULL
,	NULL
H.	NULL
Mitsuya	NULL
,	NULL
S.	NULL
G.	NULL
Irving	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1990	NULL
.	NULL

Expression	NULL
of	NULL
a	NULL
zinc	NULL
finger	NULL
gene	NULL
in	NULL
HTLV-I-	NULL
and	NULL
HTLV-II-transformed	NULL
cells	NULL
.	NULL

Science	NULL
248:588-591	NULL
.	NULL

Zipfel	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
S.	NULL
G.	NULL
Irving	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1989	NULL
.	NULL

Complexity	NULL
of	NULL
the	NULL
primary	NULL
genetic	NULL
response	NULL
to	NULL
mitogenic	NULL
activation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:1041-1048	NULL
.	NULL

